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Summary
While research and population surveys in HIV/AIDS are well established in
developed countries, Sub-Saharan Africa is still experiencing scarce HIV/AIDS
information. Hence it depends on results obtained from models. Due to this
dependence, it is important to understand the strengths and limitations of
these models very well.
In this study, a simple mathematical model is formulated and then extended
to incorporate various features such as stages of HIV development, time delay
in AIDS death occurrence, and risk groups. The analysis is neither purely
mathematical nor does it concentrate on data but it is rather an exploratory
approach, in which both mathematical methods and numerical simulations
are used.
It was found that the presence of stages leads to higher prevalence levels in
a short term with an implication that the primary stage is the driver of the
disease. Furthermore, it was found that time delay changed the mortality
curves considerably, but it had less effect on the proportion of infectives. It
was also shown that the characteristic behaviour of curves valid for most
epidemics, namely that there is an initial increase, then a peak, and then
iii
a decrease occurs as a function of time, is possible in HIV only if low risk
groups are present.
It is concluded that reasonable or quality predictions from mathematical
models are expected to require the inclusion of stages, risk groups, time
delay, and other related properties with reasonable parameter values.
Opsomming
Terwyl navorsing en bevolkingsopnames oor MIV/VIGS in ontwikkelde lande
goed gevestig is, is daar in Afrika suid van die Sahara slegs beperkte inligt-
ing oor MIV/VIGS beskikbaar. Derhalwe moet daar van modelle gebruik
gemaak word. Dit is weens hierdie feit noodsaaklik om die moontlikhede en
beperkings van modelle goed te verstaan.
In hierdie werk word ´n eenvoudige model voorgeleˆ en dit word dan uitgebrei
deur insluiting van aspekte soos stadiums van MIV outwikkeling, tydvertrag-
ing by VIGS-sterftes en risikogroepe in bevolkings. Die analise is beklem-
toon nie die wiskundage vorme nie en ook nie die data nie. Dit is eerder ´n
verkennende studie waarin beide wiskundige metodes en numeriese simulas˙ie
behandel word.
Daar is bevind dat insluiting van stadiums op korttermyn tot hoe¨r voorkoms
vlakke aanleiding gee. Die gevolgtrekking is dat die primeˆre stadium die
siekte dryf. Verder is gevind dat die insluiting van tydvestraging wel die
kurwe van sterfbegevalle sterk be¨ınvloed, maar dit het min invloed op die
verhouding van aangestekte persone. Daar word getoon dat die kenmerkende
gedrag van die meeste epidemie¨, naamlik `n aanvanklike styging, `n piek en
vdan `n afname, in die geval van VIGS slegs voorkom as die bevolking dele
bevat met lae risiko.
Die algehele gevolgtrekking word gemaak dat vir goeie vooruitskattings met
sinvolle parameters, op grond van wiskundige modelle, die insluiting van
stadiums, risikogroepe en vertragings benodig word.
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Chapter 1
Introduction
1.1 Motivation
HIV is the human immunodeficiency virus that causes the acquired immun-
odeficiency syndrome (AIDS). When a person is infected with HIV, the virus
enters the body and lives and multiplies primarily in the white blood cells.
These are the immune cells which normally protect us from diseases. The
hallmark of HIV infection is the progressive loss of a specific type of immune
cell called T-helper or CD4 cells. As the virus grows, it damages or kills
these and other cells. Eventually, this leads to AIDS, a disease caused by the
break - down of the body’s immune system making it unable to fight off op-
portunistic infections and other illnesses that take advantage of a weakened
immune system.
HIV emerged in 1980s. It is a sexually-transmitted disease which occurs
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throughout the world. Its greatest impact is found in Sub-Saharan Africa.
In 2005, the Joint United Nations Programme on HIV/AIDS (UNAIDS) and
the World Health Organization (WHO) estimated 40.3 million people to be
living with HIV in the world, 4.9 million newly infected and 3.1 million AIDS
deaths occurred in the year. Of these, 25.8 million lived in Sub-Saharan
Africa with 3.2 million new infections and 2.4 million AIDS deaths occurring
in the same year [1]. These estimates have increased from the numbers
recorded in 2003 under which 37.5 million were living with HIV, with 4.6
million newly infected and 2.8 million AIDS deaths. With these estimates,
the disease is seen to continue destroying the world’s population especially
the Sub-Saharan region.
The forementioned data on the spread of the HIV/AIDS epidemic are esti-
mate values from models derived from scarce surveys. In African countries
little research and few population or household surveys are done to get the
real picture of the spread and effect of the HIV/AIDS epidemic in the pop-
ulation. These countries thus rely much on estimates produced by mathe-
matical models. In South Africa, for example, data from models such as the
ASSA model have been showing that by the start of the year 2004, about
4.9 million HIV infected individuals were estimated. On the other hand the
UNAIDS came up with 5.6 millions HIV infected individuals [2]. The need
for more population surveys and research is thus evident. More surveys also
help in improving models and finding model parameters which lead to better
estimates.
Since HIV research is still not well developed in Sub-Saharan Africa, mathe-
matical models provide the best guide for various aspects of the spread of the
disease. Apart from providing this alternative route, mathematical models
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also provide researchers with almost instant results on studies that would
have required several months or years to conduct in the populations. They
thus help researchers and Governments to make complex choices on mea-
sures to control the transmission of the virus to the susceptible individuals.
Mathematical models are constantly improving using the available data.
It is said that 95% of the world’s HIV infected population [3] resides in
developing countries. The accuracy of such statements depends clearly on
how well the disease is modelled in less developed countries.
1.2 Thesis Objective
HIV prevalence estimates and projections based on fitting prevalence data
are relatively insensitive to the specification of demographic rates such as
birth and death rates, but absolute population size is more dependent on
these rates. For risk groups where the demography is poorly specified, es-
timates of HIV cases or AIDS deaths must therefore be interpreted with
caution. To generate a widely applicable model of the HIV epidemic much
complexity has been ignored. The priority for improving estimates is to im-
prove the coverage of sentinel sites, to understand the biases in sentinel data,
clinical and biological information, socio-economic diversity, and to include
behavioural data in surveillance. The question arises;
As the quality of data improves, can models that inform policy produce
quality information on HIV/AIDS?
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This study investigates aspects of the above question. To do that, we develop
and study some simple HIV/AIDS spread models that may help us in under-
standing uncertainties that might occur in models and give a general idea on
how one might get different results, or draw wrong conclusions, depending
on the factors taken into account by the model.
The broader goal of this thesis is to make use of mathematical models to
explore how different properties when incorporated in models may change
estimates. If these properties exist among populations;
What contribution do they make in the spread of the disease?
This study also addresses this question.
1.3 Thesis outline
Having given the motivation of this work and its general objective, the rest
of this thesis is structured as follows.
In chapter 2, a simple model is developed using ordinary differential equa-
tions to study the dynamic behaviour of HIV in the community. Since clinical
studies have been showing the progression of HIV infected individuals from
one stage to another, this model is extended to include stages of HIV pro-
gression. The results are compared to reveal the effect of introducing stages
in HIV models.
In chapter 3, the staged model developed in chapter 2 is extended to include
a time delay in AIDS death occurrence. The model is then used to investigate
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the effects of the delay on estimates.
Chapter 4 extends the simple single stage model developed in chapter 2 to
include risk groups, with different risks of contracting HIV. The very large
effect this has on predictions is explained and disscussed.
In chapter 5, we summarize our findings and give some future directions
which follow naturally from our work.
Chapter 2
The effect of Stages of
progression in HIV Models
In this chapter, two models for the spread of the HIV epidemic occur-
ring via any transmission mechanism, except of mother-to-child transmis-
sion (MTCT), are formulated and studied. The two models have different
characteristics. The first model is a simple model that describes the basic
dynamic behaviour of the spread of HIV epidemic in the population and the
second model is an extension of the first model to cater for the concept of
HIV progression of an infected individual. The main idea of this chapter is
based on the study done in Rakai - Uganda between 1994− 1999 [4, 5]. This
study revealed the correlation between the stages of HIV infection and the
transmission of the viruses to uninfected individuals. The study found indi-
viduals in the primary stage to be the leading group in the spread of HIV.
This finding can not only be used to study how important stages of HIV
infection are in the spread of the epidemic, but it is helpful in evaluating the
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efficiency of HIV spread models that are used in projecting countries’ HIV
burden as well. Therefore, this chapter investigates the effects that occur if
stages are included in HIV models.
2.1 Introduction
The study of an epidemic, such as HIV, and its spread process in any commu-
nity, is different to an investigation in many other sciences. Data can not be
obtained through experiments in the population, but can only be obtained
from surveys and results of which are found in published or unpublished doc-
uments. These data are often not complete and not accurate and may vary
with respect to methods used to collect them. Mathematical modelling and
numerical simulation play an important role in analyzing the behaviour of
the epidemic, measuring its past, present and future effect in a society.
It has been well established that HIV transmission is not uniform. It differs
from one stage to another [4, 5, 6]. Hence epidemiologic modelling must use
stages of HIV progression in order to capture the dynamics of transmission
of the disease in the population.
As an infected person progress from one stage of HIV infection to another,
the level of transmitting the viruses to others changes. Therefore, the trans-
mission dynamics of the viruses can be categorized according to the stages of
HIV progression of an infected individual. These stages of disease progression
are divided into three phases [7, 8] as it is explained below:
Primary infection stage
This stage follows soon after the initial infection when infectiousness
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Movement
Primary Asymptomatic AIDS
DeathNew Infection
Figure 2.1: A schematic diagram for HIV progression of an infected individual
first rises and then drops. Seroconversion1 typically occurs well before
the end of the primary stage. During this phase the virus is distributed
to many different organs of an infected individual.
Asymptomatic stage
During this period infectiousness is low, it produces few, if any, symp-
toms and the patient’s blood contains a relatively small viral load, and
antibodies to the virus. These antibodies are the basis of the most
common test for HIV infection.
Symptomatic or AIDS stage
It is a period (1 − 2 years until death in cases without treatment) for
which infectiousness rises again. The symptomatic stage begins while
individuals are relatively healthy and active, although it also includes
the more severe AIDS phase for which they develop AIDS and die.
Viral levels also vary greatly between these three stages. During the period
1Seroconversion period is defined as a time during which a person who has an infection
does not test positive for it. This period occurs before a person has produced a high enough
number of antibodies for a test to detect the condition. The length of the seroconversion
period depends on the type of infection. During the seroconversion period, an infected
person can transmit the disease or condition even if he or she does not have signs of the
infection.
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of primary infection, viral levels are typically high. The viral levels drop
as one enters the asymptomatic period, followed by a symptomatic/AIDS
stage during which the viral loads are extremely high. This has been evident
from a number of studies. For example, a community-based study for which
consenting couples, whether discordant for HIV or not, were prospectively
followed for 30 months to evaluate the risk of transmission in relation to viral
load and other characteristics in Rakai - Uganda. This study discovered that
the risk of infection increases as the HIV infected person’s viral load increases
[4]. In some other studies [9] it was postulated that the level of infecting for
individuals carrying HIV is dependent on clinical status of the individual.
Most of the infections an infected person causes occur shortly after infection,
after which infections become low until the immune system begins to be
seriously affected.
This variation in the levels of transmitting the disease over time can be ex-
plained using mathematical models in which infected individuals sequentially
pass through a series of stages as described above [5, 4]. Thus, in this regard
the present chapter tries to address the following questions: What effect does
the transmission rate have on the spread of the epidemic and its predictive es-
timates? Does the survival period of infected individuals have any effect? In
a situation where infected people progress from one stage to another, some of
which have indicated to have more effect in terms of transmission, we desire
to address the following question: What is the role of incorporating stages
in models that give predictions of the HIV/AIDS burden given that all HIV
infected persons pass through different stages in developing AIDS?
Currently we are faced with the need to predict the dynamics and transmis-
sion of transmitted diseases with a greater accuracy and over longer periods
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of time, and more often with limited empirical data. In most epidemiological
models, the assumption of constant total populations is often made. This
assumption is only reasonable if the disease studied spreads for a short time
only with limited effects on mortality and births. The relevance or validity of
this assumption becomes not applicable when dealing with long time diseases
such as HIV/AIDS. In such diseases, the effects of changes in population size
and disease induced mortality are far from negligible and in fact can have a
crucial influence on the dynamics of the disease.
Various mathematical models of diseases have dealt with a variable popula-
tion size [10, 11, 12, 13, 14, 15]. The interactions between the epidemiological
and demographic processes yield new features which are not found in epi-
demiological models with constant population size. For example, when the
disease persists in the population, the disease related mortality and the re-
duced reproduction of infected individuals can reduce the growth rate or
change a growing population into a population with a stable or even a de-
creasing size [16].
The HIV/AIDS epidemic has known to have a large impact in the population
as a whole [1, 3] in some regions of the world. Considering a constant pop-
ulation might be not realistic as it is in some long time diseases. However,
this assumption in the context of HIV/AIDS can be made in countries where
the prevalence of HIV is low. Our study is therefore considering a variable
size population.
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2.2 The Simple HIV epidemic model
This section presents a simple model for the spread of HIV. It might not be
realistic, but we present and analyze it so that other more complex models
of HIV spread can be easily understood.
2.2.1 Model formulation
The HIV/AIDS model formulated in the present section considers the whole
population in a single group. The assumption is made that the susceptible
population, Z(t) is homogeneous and the variations in risk behaviour, and
many other factors associated with the dynamics of the HIV spread are not
considered. The model does not contain assumptions about the mechanism of
infection. It could be homosexual or heterosexual or any other means. How-
ever, the assumption that no fertility reduction for HIV infected individuals
(Y (t)) is made and vertical transmission, (i.e. mother to child transmission)
is ignored.
The demography of the model is described by the rates of entry and exit
of individuals from the population. The larger population of susceptible
individuals is assumed free of HIV initially and together with Y (t) at time t
provide a large source of uninfected individuals entering the population. The
parameter b is the rate at which new individuals are recruited through births
into the susceptible population. People exit from the population at a rate
µ for which 1/µ is the life expectancy of individuals when the population
is free from the invasion of the disease. The parameter γ is the rate at
which the infected individuals die of the HIV/AIDS disease. In this model,
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an exponential decrease of the infected group due to disease mortality is
assumed.
The dynamics of the model are governed by the following system of differen-
tial equations:
dZ(t)
dt
= bN(t)− r
Z(t)Y (t)
N(t)
− µZ(t)
dY (t)
dt
= r
Z(t)Y (t)
N(t)
− µY (t)− γY (t) (2.1)
where r is the disease transmission rate and N(t) is the total population
given by N(t) = Z(t) + Y (t). Therefore the total population is given by
dN(t)
dt
= (b− µ)N(t)− γY (t) (2.2)
In a real situation, in most countries, the total populations varies. This is
because the births are not equal to the deaths (b 6= µ). However, even if b = µ
the population does not remain constat because of increased mortality due
to AIDS which is responsible for the term −γY (t). Therefore we formulate
this model for this requirement.
All parameters in the above model are positive and it is simple to show that
the system is well posed in the sense that if the initial data (Z(0), Y (0)) are
in the two dimension positive region, then the solutions will be defined for
all t ≥ 0 and remain in this region.
Due to the fact that the total population varies, it is convenient to work
with the proportions of the subgroups in the population. With varying pop-
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ulation, steady states are not expected in any parts of the population but
they may occur for the proportions, therefore we formulate the model above
(2.1) into equations for the proportions. We define z(t) = Z(t)/N(t) and
y(t) = Y (t)/N(t) and obtain the following system that describes the dynam-
ics of the proportion of individuals in each class
dz(t)
dt
= b− rz(t)y(t)− bz(t) + γz(t)y(t)
dy(t)
dt
= rz(t)y(t)− by(t)− γy(t) + γy2(t) (2.3)
For which the system (2.3) is positively invariant in the region
D = {(z, y) : z(t) ≥ 0, y(t) ≥ 0, z(t) + y(t) = 1}
It is observed from system (2.3) that the system does not involve the total
population N(t) at all, and therefore the behaviour of the proportions can
be analyzed without involving N(t).
Note that the population sizes of each class can be obtained from the equation
dN(t)
dt
= {b− µ− γy(t)}N(t) (2.4)
which integrates to
N(t) = N0 exp
{
(b− µ)t− γ
∫ t
0
y(t)dt
}
. (2.5)
Using the assumption we made above of constant demographical parameters
of births and deaths, the variations and dynamics of the total population
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are strongly governed by the proportions of those who are infected in the
population (see equation (2.5)).
2.2.2 Model Analysis
The analysis of this model seeks to deriving stability conditions of the equi-
librium points. Thus, we first define an equilibrium point as follows:
Definition 2.2.1 Given a system of differential equations (X˙(t)), an equi-
librium point of this system is a point in the state space for which X(t) = X∗
is a solution for all t.
In the standard approach of calculating the equilibrium points, the deriva-
tives simultaneously need to go to zero. In a variable population where all
subpopulations are changing, this is not the case. This approach is not ap-
plicable in the system under consideration. However, for the proportions,
the derivatives can be zero simultaneously. Thus, we calculate equilibrium
points and perform the analysis using the system with proportions.
A threshold factor,
χ =
r
(b+ γ)
(2.6)
is obtained using the system in equation (2.1) above. It is simply a product
of the transmission rate r and 1/(b+ γ). It is a dimensionless quantity that
represents the average number of secondary infections caused by an infective
individual introduced into a completely susceptible population. Note that
χ is a measure of the potential of a disease to spread in a population but
2.2. The Simple HIV epidemic model 15
it is not a measure of the rate at which the disease will spread. If χ < 1,
the disease cannot successfully invade the host population, and eventually
dies out; if χ > 1, however, the disease can invade, therefore producing an
epidemic outbreak that in many cases ends up in the establishment of an
endemic disease as a steady state in the population.
In the following theorem, we state and prove our result about the equilibrium
points.
Theorem 2.2.2 For r > γ, the system in (2.3) always has a disease free
equilibrium DFE = (1, 0) if χ < 1 and a unique endemic equilibrium point
EEP = (z∗, y∗) with z∗ = b/(r− γ) and y∗ = r(χ− 1)/χ(r− γ) exist only if
χ > 1.
Proof. From the second equation of (2.3) with the right hand side equal to
zero at the large t, it can be seen that the equilibrium points must satisfy
y∗ = 0 (2.7)
or
y∗ =
r − (γ + b)
(r − γ)
(2.8)
if
z∗ = 1− y∗. (2.9)
Substituting (2.7) and (2.8) in (2.9) or in the first equation in (2.3) with the
right hand side equal to zero gives z∗ = 1 or z∗ = b/(r − γ) respectively.
But (2.6) can be rewritten as b + γ = r/χ and substituting it in (2.8) gives
y∗ = r(χ − 1)/χ(r − γ). If χ < 1, then the only equilibrium in the region
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D is DFE = (1, 0); if χ > 1 then the only equilibrium in D is EEP =
(b/(r−γ), r(χ−1)/χ(r−γ)). Therefore, the model has only two equilibrium
points. 
The local stability of the equilibria of the system in (2.3) is analyzed by
linearizing the system through the introduction of small perturbations (ζi,
i = 1, 2) at the equilibrium points as
z = z∗ + ζ1
y = y∗ + ζ2
and Substituting them in (2.3) while discarding terms of higher order than
one (first) since ζ1 and ζ2 are very small quantities gives
dζ1
dt
= (γy∗ − b− ry∗)ζ1 + (γz
∗ − rz∗)ζ2
dζ2
dt
= ry∗ζ1 + (rz
∗ − (b+ γ) + 2γy∗)ζ2 (2.10)
under which the coeffients of the perturbations gives the following Jacobian
matrix which is then used to study the stability of the equilibria:
J =

 γy∗ − b− ry∗ γz∗ − rz∗
ry∗ rz∗ − (b+ γ) + 2γy∗

 (2.11)
At the disease free equilibrium, equation (2.11) will have the following char-
acteristic equation:
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λ2 − (r − 2b− γ)λ+ (b2 + bγ − br) = 0 (2.12)
with eigenvalues λ1 = −b and λ2 = r−(b+γ). By looking at the eigenvalues,
one can easily see that the disease free equilibrium is stable if r < b + γ for
which the two eigenvalues are real and negative under which χ < 1 and
unstable if r > b+γ (χ = r/(b+γ) > 1) making the two eigenvalues to be of
opposite signs with one solution (λ1) approaching the equilibrium while the
other (λ2) moving away from the equilibrium point enabling the disease to
spread in the population.
Turning to the endemic equilibrium and studying its stability; the Jacobian
matrix (J |EEP ) evaluated at an endemic equilibrium point gives the following
characteristic equation:
a2λ
2 − a1λ+ a0 = 0 (2.13)
with
a2 = 1 (2.14)
a1 =
{
r(χ− 1)
χ(r − γ)
(3γ − r) +
rb
r − γ
− 2b− γ
}
(2.15)
a0 =
r2(χ− 1)
χ(r − γ)
{
2γ2
χ(r − γ)
+ γ + b+ br
}
+ bγ + b2 − B (2.16)
where
B =
[
r3(χ− 1)
χ(r − γ)2
{
b+
2γ(χ− 1)
χ
}
+
γr(χ− 1)
χ(r − γ)
(γ + 3b) +
rb2
r − γ
]
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If χ > 1 this implies that r > γ + b and therefore we can easily see that the
trace, tr(J |EEP ) = a1 < 0 since
{
3γr(χ− 1)
χ(r − γ)
+
rb
(r − γ)
}
<
{
r2(χ− 1)
χ(r − γ)
+ 2b+ γ
}
and the determinant, det(J |EEP ) = a0 > 0 since
{
r2(χ− 1)
χ(r − γ)
}{
2γ2
χ(r − γ)
+ γ + b+ br
}
+ bγ + b2 > B,
thus by the Routh-Hurwitz criterion, all the eigenvalues have negative real
parts and therefore the endemic equilibrium point is stable. On the other
hand if χ < 1, then a1 < 0 and a0 < 0 while a2 > 0 thus, this makes
one of the eigenvalue to have a positive real part. Therefore the endemic
equilibrium point is unstable
2.3 The simple HIV staged model
The model studied in section (2.2) is extended to include stages of HIV
progression of which an infected individual passes through. The infected
persons are assumed to undergo a three stage progression of medical states
that may be classied on the basis of CD4 cells counts per cubic milliliter as
explained in section (2.1).
Lin et al [17] have studied a similar model that involved stages of HIV pro-
gression in a general way. This model was analyzed mathematically and
some stability conditions under which the equilibrium points are stable were
derived. In a similar manner, McCluskey [18] also studied a similar model
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but with an extension to include the effect of antiretroviral therapies (ART).
Under the use of treatment therapies, an infected individual returns to the
previous stages of HIV progression.
Approaching such a problem or a model solely by mathematical analysis, one
can face difficulties in understanding the practical part of the disease. It is
not possible to know whether the conditions derived in a pure mathematical
analysis have meaning or bring sense in respect to the disease in question
when it comes to a practical application. For instance, under stability anal-
ysis; one can claim the disease to have approached its equilibrium (clearance
or persistence). This might happen in some cases after a very long time has
elapsed which might however not be relevant to the epidemic and meaningful
to the society. With the numerical approach, one is able to observe whether
the disease clearance or persistence occurs within a range of time that have
meaning in relation to the kind of epidemic studied and be able to evaluate
whether the model developed is good or not. We approach the problem from
both the mathematical analysis and the numerical simulation of the model
side. This makes it different from what has been done before.
2.3.1 The description of the model
In the present model, homogeneity of susceptible individuals Z(t) is assumed
again, and also the inflow of individuals from recruitment rate b and outflow
due to natural death rate µ is maintained. The infected population is as-
sumed to be subdivided into two subgroups Y1(t) and Y2(t) according to
different infection stages of the HIV disease such that infected susceptible in-
dividuals enter the first subgroup Y1(t) and then fairly quickly progress from
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subgroup Y1(t) to Y2(t). The rate of progression from Y1(t) to Y2(t) is ρ. This
rate is assumed to be a constant that is derived from the time (1/ρ) that an
infected individual spends (waiting times) in the primary stage. Perelson et
al [7, 8] described the waiting times in the first stage of HIV progression to
be of about 2 to 10 weeks. The rate at which infected individuals in Y2(t)
become removed or sexually inactive or uninfectious due to end-stage disease
(becoming sick) is γ. Individuals in Subgroup Y2(t) are said to stay there for
a period of 10 to 15 years [7, 8] which sets the value of 1/γ.
The dynamics of the transmission of the HIV epidemic are governed by the
following nonlinear system of ordinary differential equations:
dZ(t)
dt
= bN(t)− r1
Z(t)Y1(t)
N(t)
− r2
Z(t)Y2(t)
N(t)
− µZ(t)
dY1(t)
dt
= r1
Z(t)Y1(t)
N(t)
+ r2
Z(t)Y2(t)
N(t)
− µY1(t)− ρY1(t) (2.17)
dY2(t)
dt
= ρY1(t)− µY2(t)− γY2(t)
In the model above (2.17), the total active population alive at time t is given
by:
N(t) = Z(t) + Y1(t) + Y2(t). (2.18)
The parameters r1 and r2 determine transmission rates for interactions be-
tween the susceptible individuals and infected individuals in Subgroups Y1(t)
and Y2(t) respectively. In a study done by Quinn et al [4] in Uganda showed
that the transmission of the viruses from individuals in the primary stage
to the individuals in the susceptible group is higher than those in the later
stages, and therefore r1 > r2.
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For convenience in the analysis and for reasons already given in section
(2.2), we change the system of differential equations (2.17) above to frac-
tions/proportions of the total population z(t) = Z(t)/N(t), y1(t) = Y1(t)/N(t)
and y2(t) = Y2(t)/N(t) in the susceptible and infectious classes respectively.
We have a variable population size, and the relations are:
dz(t)
dt
=
1
N(t)
[
dZ(t)
dt
− z(t)
dN(t)
dt
]
dy1(t)
dt
=
1
N(t)
[
dY1(t)
dt
− y1(t)
dN(t)
dt
]
(2.19)
dy2(t)
dt
=
1
N(t)
[
dY2(t)
dt
− y2(t)
dN(t)
dt
]
where
dN(t)
dt
= {b− µ− γy2}N(t) (2.20)
integrating to
N(t) = N0 exp
{
(b− µ)t− γ
∫ t
0
y2(t)dt
}
. (2.21)
The dynamic behaviour of the total population in this model is mainly gov-
erned by the group of people who are in the asymptomatic stage of HIV
infection (y2(t)). This is because it is only in this group that people die of
AIDS which is signified by the higher death rate γ.
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Having done some algebra the proportions of the Subpopulations are:
dz(t)
dt
= b− r1z(t)y1(t)− r2z(t)y2(t)− µz(t)− z(t)(b− µ− γy2(t))
dy1(t)
dt
= r1z(t)y1(t) + r2z(t)y2(t)− (ρ+ µ)y1(t)− y1(t)(b− µ− γy2(t))
dy2(t)
dt
= ρy1(t)− (γ + µ)y2(t)− y2(t)(b− µ− γy2(t)) (2.22)
with
z(t) + y1(t) + y2(t) = 1 (2.23)
The above system of equations (2.22) have a feasible region which is positively
invariant given by:
U = {(z(t), y1(t), y2(t)) : z(t) ≥ 0, y1(t) ≥ 0, y2(t) ≥ 0, z(t) + y1(t) + y2(t) = 1}
(2.24)
with all parameters being positive.
Using the model we study here, one can simply measure both the incidence
and the prevalence of the disease. We define the incidence of the disease as
the proportion of new cases occurring in a population during a defined time
interval. We calculate it as follows:
I =
y1(t)
〈t〉
(2.25)
with I being the incidence and 〈t〉 is the average time spent in the primary
stage defined as
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〈t〉 =
∫
∞
0
t exp (−(ρ+ µ)t)dt∫
∞
0
exp (−(ρ+ µ)t)dt
(2.26)
We also define the prevalence as the proportion of infectives in a population.
While the prevalence is given by y1 + y2, one can easily assume that the
prevalence is y2 because the time spent by newly infected individuals in the
primary stage is so short.
2.3.2 Analysis of the model
This model has two infective groups. We determine the threshold quan-
tity of this model using the Next-generation technique as presented by Van
Den Driessche [19] for compartmental models especially those with several
infected groups as shown in Appendix A.
The spectral radius of equation (A.6) is the maximum value of the eigenvalues
which gives the effective threshold quantity of the model as:
χ = r1
(ρ+b)
+
{
ρ
ρ+b
}
r2
(γ+b)
(2.27)
In this case, the threshold quantity of the model χ is a linear combination
of the threshold quantity of the Subgroups of the infected individuals in
the primary stage, Ry1 = r1/(ρ + b) and in the asymptomatic stage, Ry2 =
r2/(γ + b) of the disease progression. A factor κ = ρ/(ρ+ b) can be defined
as the probability that an infective individual will leave the primary stage of
infection and enter the next stage of the asymptomatic infection.
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Because of variable population size, system (2.22) is more complicated for
calculating the equilibrium points especially the endemic equilibrium. There-
fore a different approach from the standard method is used under which the
dynamic behaviour of the population size (equation (2.21)) is considered.
But, before we do this, our first result is a theorem concerned with the exis-
tence of this equilibrium. For this, we use our threshold obtained in equation
(2.27). (Our proof to this theorem is similar to the one given by Lin et al
[17]). Therefore, we start with the following definition:
Definition 2.3.1 If as t → ∞ an equilibrium is reached, we can define the
equilibrium values as y2(t)→ y
∗
2, y1(t)→ y
∗
1, and z(t)→ z
∗.
Theorem 2.3.2 The system in (2.22) has a unique endemic equilibrium
point if the threshold quantity χ > 1 and a disease free equilibrium other-
wise.
Proof. When the equilibrium is attained, the right hand side of system (2.22)
become equal to zero. Using the third equation of equation (2.22) we obtain
y∗1 =
(γ + b− γy∗2)y
∗
2
ρ
. (2.28)
Substituting (2.28) in the second equation in (2.22) with (2.23) gives:
a0y
∗4
2 + a1y
∗3
2 + a2y
∗2
2 + a3y
∗
2 = 0 (2.29)
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where
a0 = −γ
2r1
a1 = −(2γr1(γ + b)− r1ργ − r2ργ + γ
2ρ)
a2 = −(r1ργ + r1(γ + b)
2 + r1ρ(γ + b) + r2ρ(γ + b) + r2ρ
2 − γρ(ρ+ b)− γρ(γ + b))
a3 = ρ(ρ+ b)(γ + b) [χ− 1] (2.30)
Equation (2.29) gives y∗2 = 0 always.
If y∗2 6= 0, then (2.29) becomes
F (y∗2) = a0y
∗3
2 + a1y
∗2
2 + a2y
∗
2 + a3 = 0 (2.31)
But we know that y∗2 ∈ (0, 1), thus F (0) = ρ(ρ+ b)(γ+ b) [χ− 1] and F (1) =
r2ργ−γ
2(r1+ρ)−(γ+b)
2(ρ+b)
[
χ+ ρ
γ+b
]
. If χ < 1 then F (0) < 0 & F (1) < 0;
if χ > 1 then F (0) > 0 & F (1) < 0. But also, F
′
(y∗2) < 0 since a0 < 0,
a1 < 0, and a2 < 0 which makes the end points F
′
(0) < 0 and F
′
(1) < 0 for
0 ≤ y∗2 ≤ 1. Thus, this shows that F (y
∗
2) is a decreasing function. Therefore,
there is a unique root y∗2 which accounts for the endemic equilibrium when
χ > 1 and a disease free equilibrium otherwise. 
If the system approaches a disease free equilibrium, then
∫ t
0
y2(t)dt → c0
(constant) asymptotically and the total population in equation (2.21) change
according to
N(t) = N0e
(b−µ)te−γc0 (2.32)
But in this case, c0 = 0. Therefore, if b−µ < 0, then N(t) decays asymptot-
ically exponentially, N(t) remains constant if b − µ = 0, and grows asymp-
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totically exponentially if b − µ > 0. Thus, since y2(t) → 0 asymptotically,
then from the third equation in (2.22), y1(t)→ 0 asymptotically and also by
(2.23) and (2.24), z(t) → 1 asymptotically. Therefore, by 2.3.1, the disease
free equilibrium P0 = (z
∗, y∗1, y
∗
2) = (1, 0, 0).
If the system approaches the endemic equilibrium as it is proved in theorem
2.3.2, then
∫ t
0
y2(t)dt → c1 + y
∗
2t asymptotically with c1 =
∫ T
0
y2(t)dt − y
∗
2T
therefore from (2.21) we have
N(t) = N∗0 e
ct (2.33)
where N∗0 = N0e
c1 and
c = b− µ− γy∗2 (2.34)
N(t) decays asymptotically exponentially if c < 0, remains constant if c = 0
and grows asymptotically exponentially if c > 0. Since 0 < y∗2 < 1, then
c ranges from b − µ − γ when y∗2 → 1 to b − µ when y
∗
2 → 0 (i.e c =
(b− µ− γ, b− µ)).
From (2.34), we obtain y∗2 = (b − µ − c)/γ and Substituting this in the
third equation in (2.22) we have y∗1 = (µ+ γ + c)(b − µ − c)/γρ. By (2.23),
z∗ = γρ− (µ+ γ + c− ρ)(b− µ− c)/γρ which gives the endemic equilibrium
Pe = (z
∗, y∗1, y
∗
2).
To analyze the stability of the equilibria, we establish a Jacobian matrix J
and employ the Routh-Hurwitz technique to study the local stability of the
equilibria. The Jacobian matrix of the system (2.22) is as follows:
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J =


−b− r1y
∗
1 − r2y
∗
2 + γy
∗
2 −r1z
∗ (γ − r2)z
∗
r1y
∗
1 + r2y
∗
2 r1z
∗ − (ρ+ b) + γy∗2 r2z
∗ + γy∗1
0 ρ −(γ + b) + 2γy∗2

(2.35)
At the disease free equilibrium P0, (2.35) becomes
J |(P0) =


−b −r1 (γ − r2)
0 r1 − (ρ+ b) r2
0 ρ −(γ + b)

 (2.36)
From the matrix in (2.36), we find that λ1 = −b and the rest of the eigen-
values λ2 and λ3 are obtained from
∣∣∣∣∣∣
r1 − (ρ+ b)− λ r2
ρ −(γ + b)− λ
∣∣∣∣∣∣ (2.37)
which gives a characteristic equation
λ2 − (r1 − 2b− ρ− γ)λ+ (γ + b)(ρ+ b) {1− χ} = 0 (2.38)
The roots of the characteristic equation above give the other two eigenvalues
λ2,3 =
1
2
{
(r1 − 2b− ρ− γ)±
√
(r1 − 2b− ρ− γ)2 − 4([(γ + b)(ρ+ b) {1− χ}]
}
of the Jacobian matrix obtained at the disease free equilibrium.
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Clearly we see from the eigenvalues that λ1 < 0 always, and if χ < 1 then
λ2,3 < 0, therefore the disease free equilibrium is stable. If χ > 1, then either
one or both λ2,3 > 0 and the disease free equilibrium is unstable. This is
true because χ > 1 allows the disease to spread in the population. If the
disease free equilibrium could be stable, then the endemic equilibrium could
not exist because the epidemic would die out before spreading in the entire
population.
We study the stability of the endemic equilibrium point by linearizing our
system around Pe to obtain the following characteristic equation:
a0λ
3 − a1λ
2 − a2λ− a3 = 0 (2.39)
where
a0 = 1
a1 = a+ d+ g
a2 = cab1 + ρf − g(d+ a)− ad
a3 = g(ad− bca) + ρ(be− af)
with a = (γ − r2)y
∗
2 − r1y
∗
1 − b, b1 = r1y
∗
1 + r2y
∗
2, ca = −r1z
∗, d = r1z
∗ +
γy∗2 − (ρ+ b), e = (γ − r2)z
∗, f = r2z
∗ + γy∗1, and g = 2γy
∗
2 − (γ + b). Since
all model parameters are positive, then it is clear that ca < 0, b1 < 0, d < 0,
and f > 0. But also if γ < r2 the condition that makes χ > 1, then, a < 0,
g > 0, and e < 0. Under these conditions, a1 < 0, a2 < 0, and a3 < 0 with a0
being always positive. By the Routh-Hurwitz criteria and the Descartes rule
of signs, the characteristic equation in (2.39) has roots with only negative
real parts and hence the endemic equilibrium point Pe is stable. If γ > r2,
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then a > 0, g < 0, and e > 0 and therefore, the endemic equilibrium point is
unstable.
2.4 Numerical simulation
2.4.1 Parameter values
We split the exit rate from the population into two parts; the natural death
rate, µ and the increased mortality due to AIDS, γ. We derive the values
of µ from the life expectancy 1/µ of people in a given country. In Sub-
Saharan Africa for example, majority of the young adults are expected to
live an average of 50 years [20]. Thus µ = 0.02 years−1 with the birth rate
being b = 0.03 on average for a general case might be suitable. Some cases
where AIDS has already shown its impact, for example Swaziland for which
b = µ = 0.02; Botswana and Zambia where there are higher mortality rates
than birth rates (b = 0.02 and µ = 0.03) are ignored, as the rates are due to
AIDS.
The survival times of a HIV/AIDS infected individual depends on factors like
gender, vaccination and treatment, poverty and wealth, nutrition, biological
make up and the region where the person lives. In Sub-Saharan Africa, a
region where the large majority of HIV infections are spread heterosexually
and the epidemic is more mature, there is a substantial difference in age of
infection between men and women, with women becoming infected at an ear-
lier age [21, 22, 23]. Furthermore, an approximate of 9.4 years survival time
for women and 8.6 years for men [24] has been estimated by the UNAIDS.
Vaccination and treatment of infected persons has also shown to cause a de-
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lay in developing AIDS through reduction of the number of copies of viruses
in the body [25]. This has led to an increase of survival rates of HIV positive
individuals.
Perelson et al [7, 8] has shown that an infected individual stays in the asymp-
tomatic stage of HIV progression before developing AIDS for about 10 to 15
years. In the AIDS stage an infected individual remains only for a period
of about 1 to 2 years, as it has been revealed from the Rakai study [5]. So
this confirms that the survival period of a HIV infected person can be less
or more than 10 years.
Understanding how infectious a person can be when infected, and estimating
the rate at which this person is able to transmit HIV to others, has been
difficult in the scientific community since one can not perform experiments.
Rapatski et al [6] using data from studies which were carried out in the Gay
community in San Francisco City in the USA has shown using mathematical
models (finding the best fit to data) that transmission rate of the viruses
by stage differs when an infected individual progresses from one stage to
another. The findings from the model showed that infected persons in the
primary stage are 12 times more likely to infect the susceptible than those
in the asymptomatic stage.
On the other hand, in communities such as Sub-Saharan Africa where het-
erosexual transmission is the main mode of HIV transmission, a Rakai study
by Wawer et al [5] and Quinn et al [4] presented the analysis which provides
the first empirical data on the substantial variation in transmission by stage
of HIV infection after seroconversion. The study also showed that the rate
of HIV transmission within the first two and a half months was almost 12
times higher than that observed in chronic couples. This presents observed
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evidence that the HIV transmission rate for those individuals in the pri-
mary stage of HIV progression (r1) is higher than that of individuals in the
asymptomatic stage (r2).
The transmission rate, r as used in the simple model is estimated using the
second equation in (2.3) at the steady state as
r =
b+ γ − γy∗
1− y∗
(2.40)
where y∗ is the endemic equilibrium state of infections which can take any
value in the interval (0, 1). The minimum value that r can take is b+γ when
y∗ → 0 and if y∗ → 1 then r → ∞. Therefore, our model shows that r can
take any value in (b+ γ,∞).
According to our staged model, r1 can be calculated as a function of y
∗
2.
Writing equation two in (2.22) at the steady state in terms of y∗2 with r2 =
r1/12 gives
r1 =
(b+ ρ− γy∗2)Φ
{1− (Φ + 1)y∗2}Φ + {1− (Φ + 1)y
∗
2} /12
(2.41)
with Φ = (µ+ γ + c)/ρ and c given by equation (2.34).
As the rate at which individuals become infected is increased, the prevalence
level y∗, y∗2 at the steady state also increases (figure 2.2(a and b)). This tells
us that a careful fitting of parameters r, r1 and r2 is required when using
mathematical models to explain some biological systems such as population
and the effect of HIV/AIDS. We also find that if the rates at which people
become infected are at their minimum values, the models show a disease
2.4. Numerical simulation 32
 0
 0.1
 0.2
 0.3
 0.4
 0.5
 0.6
 0.7
 0.8
 0.9
 0.1  0.15  0.2  0.25  0.3  0.35  0.4
y*
r
(a)
γ=0.125
γ=0.1
γ=0.083
 
 
 
 0
 0.1
 0.2
 0.3
 0.4
 0.5
 0.6
 0.7
 0.8
 0.9
 1  1.5  2  2.5  3  3.5  4  4.5  5
y 2
*
r1
(b)
γ=0.125
γ=0.1
γ=0.083
 
 
 
 0
 0.001
 0.002
 0.003
 0.004
 0.005
 0.006
 0.007
 0.008
 1  1.5  2  2.5  3  3.5
y 1
*
r1
(c)
γ=0.125
γ=0.1
γ=0.083
 
 
 
Figure 2.2: A relationship between the transmission rate to the equilibrium value
for (a) y∗ (b) y∗2 in the interval (0, 1) and (c) y
∗
1 with c ∈ (−0.08, 0.01) with varying
γyear−1. Other parameters: b = 0.03, ρ = 6.0year−1 and µ = 0.02
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clearance (i.e. y∗ = 0, y∗2 = 0) and the quantity χ become equal to one. Ac-
cording to our models, a disease persists in the population if the transmission
rates are above their minimum values. The rate at which infected individuals
die due to AIDS is found to have an effect in the the equilibrium proportions.
As γ is increased, more infected people die before the equilibrium is attained
leading to low levels of y∗ and y∗2. It has also been found that y
∗
1 increases
with r1 to a peak value after which it decreases to b/ρ (figure 2.2(c) ). For
different values of the AIDS induced mortality, y∗1 is shown to increase as
γ is decreased. This is due to the fact that the survival period of infected
individuals is increased.
2.4.2 Effect of transmission rates in HIV estimation
When modelling, one has to be specific about the group of people in the
society for which the HIV prevalence estimation is to be done. General
models might lead to missunderstanding about the spread of the disease in
a general population. The results shown in figure 2.3 give clear evidence on
how difficult it can be to obtain quality information if one is to estimate the
impact of HIV in a given community.
As the rate of transmitting HIV is increased, the proportion of the infected
group rise more quickly. The increase in the transmission rates is also found
to increase χ in both models. For example, in the simple model as r is
increased from 0.167 to 0.5, χ increased from 1.28 to 3.85. In the staged
model, as r1 was increased from 2.0 to 6.0, r2 from 0.167 to 0.5, χ also
was found to increase from 1.61 to 4.82. Therefore, rates of transmitting the
disease has an impact on the spread and estimations as the potential measure
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of the disease growth (χ) has shown.
The proportions of infected individuals remain high over time after the initial
rise (figure 2.3(b) and 2.3(c)) and a different behaviour of new infections
is also shown (figure 2.3(a)). As shown, the peak occurs at high and low
transmission rates, and the proportion then drops back to a non-zero value.
However, in the epidemiology of HIV, a disease that spreads quickly, we do
not expect the peak incidence to occur after a very long period of time. Our
results show that when r1 is reduced to 2 and r2 to 0.167, the curve for new
infections peak can occur after a very long time has passed (2.3(a)). This
kind of dynamic behaviour is possible in some groups of people with low risk
behaviour under which the rate of disease acquisition is low.
Generally, the results obtained in this section have been representative of
some section of a given population. In some populations, the disease has
shown a very high impact with prevalence curves being high and incidence
having a peak at short time, while in other cases the impact of the disease
is low. In such a case, one has to avoid generalization of results to a general
population, since they may lead to overestimation or underestimation.
2.4.3 Mortality effect in the spread of the epidemic
Since the number of infections depend on the number of susceptibles which
an infected individual is able to infect, it is important to investigate the effect
of survival time. Figure 2.4 show the effect caused by the change in AIDS
mortality. As the death rate is increased, that is, as the survival period is
lowered, the proportion of infected individuals increases slowly. The increase
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Figure 2.3: Transmission effect for (a) proportion of new infections (b) Prevalence
in the staged model and (c) Prevalence in the simple model. Parameters: b = 0.03,
γ = 0.1year−1, ρ = 6.0year−1, µ = 0.02 at r1 = 6.0, 4.0 and 2.0, and r2 = r = 0.5,
0.33 and 0.167.
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in HIV infection is low because more people are dying and therefore these
have a small impact as compared to the case the AIDS mortality rates are
low. AIDS mortality can be lowered by treating HIV infected individuals.
In the developed countries and in some developing countries, including those
of Sub-Saharan Africa, the drug zidovudine (AZT) and other treatment com-
binations have suppressed the intensity of HIV development in the patients
body and thus prolonged the incubation2 period, for those who can afford
the treatment. The prolonging patients incubation period is good in the
sense that an individual lives longer and continues to serve the nation, but
at the same time, it is expensive for both the individual as well as the nation.
However, there is a danger that such patients can infect many individuals
in a more destructive way as they can practice sexual activities, which can
be a disadvantage for the society. The threshold quantity, χ proves in this
regard that as the incubation period of an infected individual is increased by
any means, the number of secondary infections also increases. For example,
when the average infected person is to survive for 8 years (γ = 0.125 year−1),
10 years (γ = 0.1year−1) or 12 years (γ = 0.08year−1); then χ have to be
2.13, 2.54 or 3.0 respectively.
Figure 2.4(a) shows a different kind of results. In the early stage of the
epidemic, the proportion of new infection curves show very similar rise during
this period. A switch between the curves occurs at the peak value and
the difference between the curves becomes large and observable during the
mature stage of the epidemic. At large t, lowering γ (increasing survival time
of infected people) causes no more infections.
2An incubation period is defined as a period from HIV infection to AIDS development.
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Figure 2.4: Mortality effect for (a) proportion of new infections (b) Prevalence in
the staged model and (c) Prevalence in the simple model. Parameters: b = 0.03,
ρ = 6.0year−1, r1 = 4.0, r2 = r = 0.33, µ = 0.02 at γ = 0.08, 0.1 and 0.125 year
−1
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2.4.4 The impact of stages in HIV predictions
To illustrate the effect of stages in this situation, we compare the results
obtained from the two models. We address the question: is it necessary
to incorporate stages of disease progression when modelling the spread of
HIV/AIDS? Particularly, we are interested in understanding whether the
inclusion of stages has or hasn’t an effect on the overall infection and pro-
gression of the epidemic in the population as well as on estimation of future
trend. If this does not have any effect, then extending the model to incorpo-
rate stages of progression is not an important factor and therefore modelling
while considering a single group of infected individuals is a better and sim-
pler way to understand the pattern of the epidemic and can produce quality
information on the disease. If the effect exists, then a careful choice of the
model is a good idea for modellers.
In comparing the two models, we run simulations by varying the transmission
rates to find out whether there exist a value for r different from r2 such that
the results for the staged model are reproduced. We found no value for r that
gives the above property. In all simulation trials performed, stages showed a
large impact at low t while the single stage model had its impact at very large
t. This made it difficult to fit the results from the two models. However, it
was possible to fit the results from the two model for lower t than for large t.
As y2 is as large as y because individuals in y1 progress to y2 within a very
short period of time, we further considered the case where r = r2 to find
out more difference on the two models during a short term. The results for
this case are shown in (figure 2.5). The results showed a clear difference in
the prevalence, AIDS mortality rate curves and the total population (figure
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2.5(a, c and d)). It was found that, the prevalence of infected individuals is
high for the simple staged model and low for the model with a single group of
infected individuals. y2 rises highly just after the epidemic starts to exist in
the population. For this example, we also found that the effective thresholds
for the two models are different being high for the staged model (χ = 2.41)
and low for the model with a single group of infected people (χ = 1.92).
This difference may be due to the contribution by the primary stage shown
in (figure 2.5(b)) because individuals in this stage are found to have a high
amount of viruses in the bloodstream which makes the transmission of the
HIV easier to others [4, 5, 8, 7].
Due to high prevalence of infected individuals, the AIDS mortality rates are
also high (figure 2.5(c)). The difference in the AIDS mortality curves for the
two models have a similar trend to that found in the prevalence curves. This
has been due to the disease increased mortality being proportional to the
prevalence levels of infected persons. As peoples’ death affects the total pop-
ulation, the impact of the epidemic is found to be different for the populations
of the two models. The population for the simple staged model experiences
a mortality impact earlier than the total population for the simple model
(figure 2.5(d)).
2.5 Summary and Conclusion
In this chapter, we formulated and explored two simple models for the spread
of the HIV epidemic one of which incorporated stages of HIV progression of
an infected individual. The local analysis of these models are performed
and numerical simulation examples are also performed to understand some
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Figure 2.5: A comparison between the simple HIV model and the staged model
for (a) Prevalence, (b) proportion of new infections, (c) AIDS mortality rates, and
(d) Total population at r1 = 3.0, r2 = r = 0.25, ρ = 6.0, γ = 0.1, µ = 0.02 and
b = 0.03
demographical and epidemiological dynamical behaviour. A comparison for
these models is also carried out to reveal the effect of introducing stages of
HIV progression.
We analyzed the effect of varying the two main parameters, the rates of
transmitting the disease r, r1, r2 and the disease caused death rate (γ). The
findings show that the rate of transmitting the viruses is the driving force
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in the spread of the disease while the disease death rate has little impact in
general.
Apart from the results found to be general for both models, there are some
specific findings shown by the staged model. When r1 and r2 are varied, a
switch between the new infection curves is found to occur at large t. This is
an interesting result which needs careful attention when dealing with disease
incidence and transmission rate. One can easily draw different conclusions
on the relation between the transmission rate and the persistence of new
infections.
From the explorations, it was found that the majority of the infectives do not
spread the disease during its early stage (figure 2.5(a)). Instead, individuals
in the primary stage play a major role in transmitting the viruses. If this
group could somehow be identified and convinced to refrain from risky be-
haviours, at least while they are highly infectious, the impact of the epidemic
could perhaps be reduced.
The results from the models gave the expected trend or behaviour of HIV/AIDS.
Since the models were formulated without considering all important factors
for the spread of HIV and simulated not by fitting parameters to any ex-
isting data, we could not expect to obtain results which are consistent with
reality. But in general, stages showed a large impact in the overall results.
It is therefore important to use this approach (incorporating stages) when
modelling the spread of the HIV.
Chapter 3
Delayed death in HIV spread
models
HIV infected patients survive for some years after they have acquired the
disease. The disease does not kill immediately, it takes some time before
weakening the immune system although the viruses replicate1 quickly in the
human body. An infected person has a long time to transmit the viruses to
other people. In such a case, a disease is to spread within the human popu-
lation and therefore cause some other unexpected dynamical behaviour. Due
to the emergence of several efforts in preventing and treating HIV patients,
treatment - drugs have been developed and they played an important role in
reducing HIV/AIDS - related mortality in industrialized countries as well as
for those who have access to them in resource poor settings. The increase in
the life expectancy of an infected individual has been due to the sustained
1reproduction and generation of new viruses
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reduction of viral reproduction by these drugs, which improves immune func-
tion and prolongs AIDS - free survival. With this motivation, this chapter
investigates the effects that may arise in estimating the impact of HIV us-
ing mathematical models. We do this by studying a model that takes into
account a constant time delay in the occurrence of AIDS death by assuming
an equal survival period in all infected individuals in any setting.
3.1 Introduction
Mathematical models of the spread of HIV/AIDS used for predictions are
constrained by the differences in survival times that exist between HIV in-
fected individuals. These differences are due to genetic heterogeneity, socio-
economic aspects of life and geographical locations. The development of
treatment interventions has also increased the differences in HIV survival
among people in developed countries and in developing nations. As there
has been no common survival time for all HIV infected individuals, the mod-
elling approach on AIDS death has become more difficult to carry out.
The Weibull distribution has been commonly used as an incubation distri-
bution [26, 27]. A similar distribution is used to explain the survival prob-
abilities of HIV infected individuals [28, 24] under which this probability
decreases as one progresses from HIV infection to death. This distribution
is found to have a good fit to data in a short term. Due to the introduction
of an effective antiretroviral therapy (ART), the incubation period defined
with approximately parameterized Weibull distribution could form a different
shape in a long term.
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Although it has been difficult to estimate the HIV survival period, HIV/AIDS
models have been studied by several authors [29, 30, 11]. Most of which have
assumed an exponential distribution of the infectious period. This assump-
tion is equivalent to assuming that the chance of dying of AIDS within a
given time interval is constant, regardless of time since infection. In the
present chapter we consider the opposite case. The case where all infected
individuals have the same survival period, and after this time has lapsed an
individual must die. Doing this, a step functional behaviour of HIV survival
is considered through the introduction of a single and constant time delay in
the occurrence of AIDS death.
In the course of developing our model, we employ a delay to mathematically
represent the time lag between the initial infection and the death of an in-
fected individual (i.e. survival period). Of interest are delay equations of the
form:
du(t)
dt
= F (u(t), u(t− τ)) (3.1)
where τ > 0 is the time delay with an initial condition being a function
defined in the interval [−τ, 0].
The application of delay equations has been carried out by many other au-
thors especially in population studies and epidemiology [31, 14], with ap-
plication to HIV spread models [10, 15, 32]. Among the deficiencies of the
models we studied in the second chapter is that we considered the entire
population. In models which consider only the sexually active population,
the recruitment rate into the adult population can not be considered to act
instantaneously as there is a time delay to take into account the time to
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adulthood. In such cases, some authors have considered this time delay that
determine the maturation of individuals moving from childhood to adult-
hood and or age structure in populations [33, 24, 34]. This time delay in
HIV/AIDS spread models is mostly considered to be 14 or 15 years that
represent the number of years for an individual to be considered an adult in
a sexually active population.
In this chapter, we further extend the deterministic model with stages of HIV
progression studied in chapter 2 to include a time delay in the occurrence
of AIDS death of HIV infected individuals. As it has been known that
HIV infected individuals do not die immediately after they are infected, they
survive for a given period of time. We devote this chapter to the investigation
of the question: Does it matter to have a delay in AIDS mortality; what effect
does this have?
3.2 Model derivation
Since the infected class is divided into two subclasses; those in the primary
stage Y1(t) and those in the asymptomatic stage Y2(t) as it has been described
in chapter 2, the mortality increase due to the disease occurs in Y2(t). Assum-
ing τ to be the expected period for an infected individual to survive which
in the present study is assumed to be constant for all infected individuals,
then Y2(t) can be redefined as an integral as follows:
Y2(t) = ρ
∫ t
0
Y1(s)e
−µ(t−s)θ(s− (t− τ))ds (3.2)
The integral is the summation of all individuals who got infected and en-
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tered Y1 at time s ≥ 0 and have remained infective through to time t. The
term e−µ(t−s) is the survivor probability of infected individuals from causes
other than HIV/AIDS. These individuals became infected at time s and have
survived to time t. Our step function θ(x) is defined as follows:
θ(x) =


1 if x ≥ 0
0 if x < 0
(3.3)
The integral in equation (3.2) when differentiated under (3.3) is equivalent
to the delay differential equation (DDE)
dY2(t)
dt
= ρY1(t)− µY2(t)− ρY1(t− τ)e
−τµ (3.4)
which describes the dynamics of the group of individuals in the asymptomatic
stage.
The term ρY1(t − τ)e
−τµ represents the number of individuals who were
infected τ years ago and have survived from natural death and are currently
dying of AIDS. Note that these individuals are in the asymptomatic stage of
HIV progression.
Therefore, the dynamics of the disease in the population with a time delay
in the AIDS death changes according to the system of nonlinear differential
equations below:
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dZ(t)
dt
= bN(t)− r1
Z(t)Y1(t)
N(t)
− r2
Z(t)Y2(t)
N(t)
− µZ(t)
dY1(t)
dt
= r1
Z(t)Y1(t)
N(t)
+ r2
Z(t)Y2(t)
N(t)
− µY1(t)− ρY1(t) (3.5)
dY2(t)
dt
= ρY1(t)− µY2(t)− ρY1(t− τ)e
−τµ
where N(t) is the population size at time t given by Z(t) + Y1(t) + Y2(t).
Note that all parameter and variable definitions in this model stay similar to
those in the previous chapters.
The total population changes exponentially in the absence of the disease, and
in the presence of the epidemic (adding the equations in (3.5)) the population
changes according to
dN(t)
dt
= (b− µ)N(t)− ρY1(t− τ)e
−τµ (3.6)
In terms of proportions; z(t) = Z(t)/N(t), y1(t) = Y1(t)/N(t),
and y2(t) = Y2(t)/N(t), the system in (3.5) gives
dz(t)
dt
= b− bz(t)− r1z(t)y1(t)− r2z(t)y2(t) + ρe
−τµz(t)y1(t− τ)α(t)(3.7)
dy1(t)
dt
= r1z(t)y1(t) + r2z(t)y2(t)− (ρ+ b)y1(t) + ρe
−τµy1(t)y1(t− τ)α(t)
dy2(t)
dt
= ρy1(t)− by2(t)− ρe
−τµy1(t− τ)α(t) + ρe
−τµy1(t− τ)y2(t)α(t)
with
y1(t− τ) =
Y1(t− τ)
N(t− τ)
(3.8)
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and
α(t) =
N(t− τ)
N(t)
. (3.9)
Equation (3.6) also becomes
dN(t)
dt
=
{
b− µ− ρe−τµy1(t− τ)α(t)
}
N(t) (3.10)
integrating to
N(t) = N0 exp(
∫ t
0
{
b− µ− ρe−τµy1(s− τ)α(s)
}
ds) (3.11)
3.3 Model Outcomes
In this section, the equilibrium points are found. A question is raised, ’How
do different parameter values affect the equilibrium points?’ To answer this
question, a full analysis in a numerical approach is applied.
3.3.1 Equilibria
Definition 3.3.1 If as t → ∞ the system in equation (3.7) attain an equi-
librium state, then we can define y1(t− τ)→ y
∗
1, y1(t)→ y
∗
1, y2(t)→ y
∗
2 and
α(t)→ α∗.
Setting the system in equation (3.7) to zero at the equilibrium and applying
the definition (3.3.1), the disease free equilibrium (1, 0, 0) is found.
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But also from the third equation we can obtain y∗2 as
y∗2 =
ρy∗1(e
−τµα∗ − 1)
ρe−τµα∗y∗1 − b
(3.12)
To calculate y∗1 from the system above is more difficult, therefore, we use a
similar approach to that used in the staged model. Using equation (3.9) and
(3.11) we can obtain
α(t) = exp
[
−τ(b − µ) + ρ exp(−τµ)
{∫ t
0
y1(s− τ)α(s)ds+
∫ t−τ
0
y1(s− τ)α(s)ds
}]
= exp
[
−τ(b − µ) + ρ exp(−τµ)
{∫ t
t−τ
y1(s− τ)α(s)ds
}]
(3.13)
Choosing t large in such a way that within the interval (t − τ, t) both α(t)
and y1(t− τ) are constant, (3.13) gives
α∗ = exp
[
−τ(b − µ) + τρe−τµy∗1α
∗
]
(3.14)
from which we find
y∗1 =
lnα∗ + τ(b− µ)
τρα∗e−τµ
(3.15)
and substituting equation (3.15) in (3.12) gives y∗2 in terms of α
∗ as
y∗2 =
ρ(e−τµα∗ − 1)(lnα∗ + τ(b− µ))
α∗ρe−τµ(lnα∗ − τµ)
(3.16)
and z∗ = 1− y∗1 − y
∗
2 which approximates the endemic equilibrium point.
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3.3.2 Relationship between transmission rate and the
equilibrium values
Since the transmission rate of HIV to uninfected individuals has been the
most important factor in the spread of the disease, we analyze its relation
to the endemic equilibrium derived in the above section. This provides us
with an understanding of the disease persistence in the population at large
t. This is in contrast to most of our discussions which are limited to a small
interval of time under which the model has physical meaning for the disease
studied.
Considering the system in equation (3.7) at the steady state, we can obtain
r1 from the second equation. Applying the definition given in (3.3.1) and the
relation r2 = r1/12, then
r1 =
(ρ+ b)y∗1 − ρe
−τµα∗y2∗1
(1− y∗1 − y
∗
2)(y
∗
1 +
y∗
2
12
)
. (3.17)
Knowing that y∗1 ∈ (0, 1), and y
∗
2 ∈ (0, 1), one can find the space in which
r1 lies. But since both y
∗
1 and y
∗
2 depend on α
∗, the ranges of steady state
variables can be different and hence change the range of r1. Thus, it is better
to find the range of α∗. To do this, we consider the condition that y∗1+y
∗
2 ≤ 1.
Therefore, from this we find α∗ ∈ (eτµ,∞).
Figure 3.1(a) shows the relation that exists between the transmission rate
and the equilibrium value for the proportion of infected individuals in the
primary stage (y∗1). The proportion of new infections increases rapidly as
r1 is increased to a critical value of r1τ dependent on τ at which y
∗
1 peaks.
3.3. Model Outcomes 51
 0.004
 0.005
 0.006
 0.007
 0.008
 0.009
 0.01
 1  2  3  4  5  6  7
y 1
*
r1
(a)
τ=8
τ=10
τ=12
 
 
 
 0.2
 0.3
 0.4
 0.5
 0.6
 0.7
 0.8
 0.9
 1
 1  2  3  4  5  6  7
y 2
*
r1
(b)
τ=8
τ=10
τ=12
 
 
 
Figure 3.1: Relationship between the transmission rate (r1) and the equilibrium
values. (a) y∗1 and (b) y
∗
2 with α
∗ ∈ (eτµ, 8) at b = 0.03, µ = 0.02, ρ = 6.0year−1,
and τ = 8, 10 and 12 years
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Above the critical value, y∗1 decreases to a non zero value. This has to do
with the fact that as the transmission rate is increased, more new infections
occur earlier (i.e. when t is small) which results in a reduction of susceptible
persons during the early stage of the epidemic. This phenomenon suppresses
y1 at large t causing it to stabilize at a lower proportion. It has been also
found that if r1 is below 1, the endemic equilibrium does not appear and only
the disease free equilibrium holds.
What we find in figure 3.1(b) is different from what we have seen in figure
3.1(a). The equilibrium level for the prevalence, y∗2 has a different kind of
relationship with the transmission rate. As r1 is increased, y
∗
2 also increases
approaching a constant value.
A reduction in the equilibrium value for the prevalence levels can be achieved
by reducing the rate at which individuals become infected. We also learn
that, focusing on the stabilization of the proportion of new infections of the
epidemic in the population can give false information on the burden and
spread of the epidemic. One might think that the rate of transmission is low
by just looking at the new infection proportion stabilization. This may also
give false information on the prevalence. In fact, even if the new infections
stabilizes at a low level, still the prevalence might stabilize at a higher level.
This also might give incorrect impression if one is to use new infections to
estimate the infection rate. This imbalance between the new infections and
prevalence stabilization cause confusion as it can give different information
on the spread of the disease in the society. Therefore, one has to be careful
when using these two different epidemiological and demographical pieces of
information to address the epidemic problem in any society since any change
in the infection rate results in a shift in equilibrium values.
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3.3.3 Transmission effect and the emergence of Oscil-
lations
Further analysis of the model (equation 3.7) shows the variation that may
occur in the proportion of new infection and prevalence curves as the trans-
mission rates are changed. The incidence curves in figure 3.2(a) shows a
quick rise when the rates are increased. Increasing the rates of transmission
enables more people who are in the risk group to acquire the disease and
therefore increase the new infections in the population. This continues until
a peak is attained, after which the curve drops very quickly in a similar man-
ner to its initial rise. But, the new infections continue while decreasing, and
eventually they stabilize at low proportions if the rates are at large values.
It has also been found that if the transmission rate is increased, a quick rise
and stabilization in the prevalence (figure 3.2(b)) occurs at very high levels
which seem to be unrealistic to have such a large fraction of the population
infected. A different behaviour for the stabilization of the prevalence when
compared to that of the proportion of new infections is also observed. Preva-
lence curves tend to stabilize at high values as r1 and r2 are increased. This
is because most of the infections occur at low t, and the fact that mortality
is delayed.
In addition we found the occurrence of small oscillations which then die out
immediately before the endemic equilibrium is achieved(figure 3.2). How-
ever, the parameter values for which these periodic solutions occur may be
unrealistic. In the special cases when b = µ = 0, b = µ 6= 0, and b 6= 0 but
µ = 0, oscillations still arise in the solutions. This leads us to a conclusion
that oscillations occurring are due to the delayed death of infected individ-
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Figure 3.2: Development of periodic solutions in the (a) new infection curves and
(b) prevalence curves for the system in (3.7) when r1 and r2 are increased from
2.0 to 6.0 and 0.167 to 0.5 respectively with b = 0.03, µ = 0.02, ρ = 6.0year−1,
and τ = 10years.
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uals. Hethcote and Van de Driessche [10] in their model that consisted of
both a variable population and a delay, found that a constant delay for the
infectious period can lead to periodic solutions. These oscillations do not oc-
cur for the analogous ordinary differential equations SIS models for example,
in which recovery is proportional to the number of infectives. It is therefore
important to understand the correlation that exist between rates of infection,
and the incidence and prevalence levels in models with delay.
3.4 The influence of a delay
This section investigates the effect that may occur as a result of introducing
a delay in the model. We do this through changing some parameter values
while leaving others unchanged and a comparison between the simple staged
model discussed in chapter 2 together with the model with delay is made to
reveal the delay effect.
3.4.1 Effect of survival time of HIV positive persons
The main difficulty with forecasting is that many different empirical curves
fit the available data; in some cases well. Although these curves give rea-
sonably consistent predictions in a short term, the predictions can be quite
divergent in a long term. ( This model ignores the possibility of changes that
occur through medical break-through. For example, to date, the effective-
ness of combination anti-retroviral therapy, have been demonstrating a large
reduction in both progressions to AIDS and AIDS-related deaths. But there
have been no data on the exact size of treatment-induced delay on AIDS
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caused mortality [35] ). Therefore, simulation results for different values of τ
(figure 3.3) are generated to investigate effects caused by the life expectancy
of infected individuals.
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Figure 3.3: Effect of the survival periods, τ years for the (a) Proportion of new
infections, y1 (b) Prevalence, y2 (c) AIDS mortality rates and (d) Total population.
Parameters: r1 = 3.50, r2 = 0.292, µ = 0.020, b = 0.030 and ρ = 6.0year
−1.
It has been found from the results that as τ is increased, predictions show
roughly similar results in a short period of about 10 years measured from
the start of the epidemic for the incidence, prevalence and the total popula-
tion. However, differences arise at large t. During low t, mortality due to the
epidemic are not occurring and people are still surviving although they are
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infected. Another related finding is that, as τ is increased, the proportion of
infected individuals in the primary stage is lowered while that in the asymp-
tomatic stage is increased. For the disease like HIV/AIDS, treatment as a
means to life extension reduces the amount of virus copies which then allows
these individuals to move back to their previous stages, the asymptomatic
stage of HIV development [18]. As the transmission rates is proportional to
the viral load [4, 5], then these individuals have a low chance to transmit the
disease.
3.4.2 A comparison with the staged model
The effect of a delay in AIDS mortality is assessed by considering the changes
in the demographics. The results of the model developed in this chapter
which takes into account the effect of delay, are compared to the results
obtained from the simple staged model (No-delay) developed in chapter 2.
The comparison is made by considering two scenarios.
Scenario one: A similar rise in the prevalence.
In this scenario, a similar rise in the prevalence curves in both models is
considered. We assume that the asymptomatic group in both models is
similar at the early stage of the disease noting that AIDS mortality in both
models have not shown their impact yet. With a similar rise in prevalence
level in this case, the prevalence level in both models is set at 40% when t
is at 20 years (figure 3.4(b)). To obtain this, the rates of transmission in
the No-delay model were set higher values (r1 = 3.065 and r2 = 0.255) than
in the model with delay (r1 = 2.689 and r2 = 0.224). This is due to the
fact that before t = 10 years, the asymptomatic group in the model without
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delay experiences disease caused mortality immediately after it starts to exist.
This is not the case for the model with delay. During this period, there is
no disease related mortality at all since the survival period of all infected
individuals is not reached at 10 years (i.e. y1(t−10) = 0). So, the prevalence
of infected individuals in this model is expected to rise more quickly than
in the model without delay. We investigated the difference that occur in
the prevalence itself at t > 20 years and study the effect that happens in
the proportions of infected individuals in the primary stage (figure 3.4(a)),
disease caused mortality rates (figure 3.4(c)) and the population size (figure
3.4(d)) for all t.
Since r1 and r2 are higher in the model without delay, most of the infections
occurs earlier and the proportion of new infections become higher during this
period (figure 3.4(a)). This results in high prevalence level (figure 3.4(b)) at
large t. The saturation of uninfected people at a low level leads to low
occurrence of new infections later. Despite the fact that the new infections
curves have a difference in their rise, still we find that they both peak at the
same time (i.e. t = 20 years) although at different levels. It is also found
the mortality rates for the model with delay to be higher than those in the
model without delay at large t. This is simply because when infected people
start dying, they do so at a very high rate in the model with delay.
The rising rates of deaths due to the disease are expected to result in a
reduction of population growth and hence a decrease of population size in
both models. The population size is affected in two ways: the first way is
due to the increase in disease ”mortality rates” and the second way is due
to a reduction in ”births” as a result of deaths occurring. Generally, it is
found that the population size in the model without delay begins to show
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Figure 3.4: A comparison between the simple staged model (No delay case) and
the model with delay while considering same initial rise in the prevalence curve
(y2). (a) Proportion of new infections, y1 (b) Prevalence, y2 (c) AIDS mortality
rates and (d) Total population. Parameters: r1 = 3.065 and r2 = 0.255 for the
No delay case and r1 = 2.689 and r2 = 0.224 for the model with delay. Other
parameters: ρ = 6.0year−1, µ = 0.02 and b = 0.03.
a decrease as the disease mortality starts to occur earlier. The population
size in the model with delay continues to grow for almost 10 years longer
measured from the time at which the population in the No-delay model start
showing a decrease. This is due to τ = 10 years as it has been used in
the numerical simulation. By the time when the mortality rises to the high
plateau values, the total population is decreased at a very high rate causing
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it to switch over with the population size for the model without delay.
Scenario two: Same transmission rates.
Having studied the scenario where the rates of transmitting the disease are
low and different, we now consider the second scenario in which large and
same values for the transmission rates are assigned in the two models. For
t < 10 years, this produces a quick and similar rise in the incidence level for
both models (figure 3.5(a)). However, at very small scale, a small difference
is observed which is not significant. Although during this period disease
caused mortality exist in the model without delay, they are not high enough
to cause a large impact. This causes the rise of the prevalence curves (figure
3.5(b)) for both models to be similar too.
During t ≥ 10 years, differences are found to occur under which the delay
results in the occurrence of oscillatory behaviour for the proportions of new
infections, prevalence, and mortality rates as y1(t − 10) 6= 0. Since y1(t −
10) takes a rise similar to y1(t) in the last 10 years, therefore, within the
time interval 10 < t < 20, the curve for mortality rates for the model with
delay (figure 3.5(c)) rises quickly. Therefore, this has a large impact in the
proportions of new infections (figure 3.5(a)), prevalence level (figure 3.5(b)),
and the population size (figure 3.5(d)). Infections in this case are allowed
to take place fast in the risk population and therefore disease mortality are
found to be lower. Hence the population size in the delay model experience
a large impact and decreases faster than in the model without delay.
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Figure 3.5: A comparison between the simple staged model (No delay case) and
the models with delay at the same transmission rates. (a) Proportion of new
infections, y1 (b) Prevalence, y2 (c) AIDS mortality rates and (d) Total population.
Parameters: r1 = 4.0, r2 = 0.33, ρ = 6.0year
−1, µ = 0.02 and b = 0.03
3.5 Summary and Conclusion
Deficiencies of national statistics in countries most severely affected by HIV/AIDS
make it difficult to assess the impact of the epidemic on mortality. When
working with limited and defective data it is important to utilize all available
sources of information. This chapter discussed a model describing the dy-
namics of the population affected by HIV and the role played by introducing
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a time delay in the occurrence of AIDS deaths for infected individuals.
It was shown that the proportion of new infections and the prevalence of
the disease are mainly determined by transmission rates not by HIV survival
period extension. The model showed these results as it was compared with
the simple staged model discussed in chapter 2. The two models did not show
a large difference in the prevalence and the proportion of infected individuals
in the primary stage of HIV progression. However, some oscillatory behaviour
in the solutions were shown though they seemed to occur at transmission rate
values which are higher than those required in most populations.
The effect of increasing HIV survival period was also investigated. The hy-
pothesis was that increasing HIV infected individuals’ survival time through
treatment increases the proportion of infected individuals in the population
or facilitate the spread of HIV as the time to continue infecting is increased.
From the model simulations, it was shown that HIV survival has a low im-
pact in the spread of the disease. Survival time was found not a facilitator
of the spread of the disease in its early stage but a low impact was found to
occur during the maturity stage.
The main finding in this chapter has been the effect of the delay in the model.
Our simulations have indicated that models of death strongly determine dis-
ease mortality rates. AIDS mortality rates for the model with delay were
found to be far higher than those in the model without delay. From this, the
results suggest that if one is to project AIDS mortality using mathematical
models, then a delay in the mortality must be included as more treatment
efforts are now in action.
Prolonged incubation periods of HIV/AIDS was found to enlarge the epi-
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demic in a model that included a time delay by Mukandavire et al [32].
Our results have shown that increasing the survival time of HIV positive
individuals may increase the prevalence of the HIV disease but decrease the
new infections in a long term. This happens due to the accumulation of
infected individuals in the asymptomatic group which measures the disease
prevalence.
Chapter 4
The role of risk groups in HIV
predictive estimates
An individual’s belief in his or her personal risk level to illness or disease is an
important element in nearly all models, both general and HIV/AIDS specific,
as it influences the adoption of risk reducing behaviour and/or preventive
strategies. Survey results for the year 2005 [21] in South Africa have shown
the presence of people (66%) who believed that they would NOT contract
HIV. However, there are differences in HIV risk levels among different groups
[23]. Some HIV models, whose projections are widely used, have included the
group of individuals NOT at risk to HIV infection in addition to groups of
various levels of risk. For instance this was done in the Epidemic Projection
Package (EPP) developed by the UNAIDS [28] and the ASSA model for
South Africa [33]. This chapter extends the models discussed in chapter 2 to
include risk groups. We do this by investigating the effect of different aspects
such as initialization, levels of risk, and the division of new recruits into the
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groups of the model
4.1 Introduction
The spread of HIV in any population varies from one group of individuals to
another due to differences in exposure. In different regions marked variations
occur in both HIV incidence and prevalence [23, 21]. The possible explana-
tions for these variations lies in the differences of risk factors. These can be
categorized into three main groups as follows:
• Behavioural factors
These include commercial and transactional sex, sex and alcohol con-
sumption, violence in sexual relationships, non-disclosure of HIV sta-
tus, and partner concurrency 1
• Socio-economic and demographic factors
These include income, education and employment, economic migration,
urban-rural differentials, age and risk factors for transmission among
intravenus drug users (IDUs)
• Biomedical factors
These include sexually transmitted infections (STIs) such as syphilis,
herpes, gonorrhoea, and bacteria vaginosis, the use of hormonal contra-
ceptive especially injectable contraceptives, and younger age especially
in women.
1Having more than one partner
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On the basis of data from Carletonville in South Africa, MacPhail et al [36]
found that among biological risk factors, susceptibility to HIV infection was
30% higher in females than in men. In a similar way, in a national population-
based survey conducted in the year 2002 in South Africa, females were found
to have a higher prevalence (about 12.8% ) than males (about 9.5%) [37].
While biological factors are clearly important, a number of survey studies
have suggested that social and behavioural factors are equally important
[21, 23]. Rehle et al [37] showed that major differences in HIV prevalence
exist within locality, province, race, and age. The study found the highest
prevalence in the African community (12.9%) followed by the white commu-
nity (6.2%), coloured (6.1%) and Indians (1.6%).
Despite these obvious differences in HIV prevalence and differences in risk
factors among individuals, most of the mathematical models of the spread
of the HIV epidemic have not captured this fully. In most models a uni-
form risk group of people is considered. In some cases the infected group is
divided according to infectiousness. We ask the question: are these models
representative? In some models the population is divided into core groups
[13, 12] and in some risk behaviour in sexually transmitted disease have been
considered [38].
When modeling while including risk groups, one need to consider how new
individuals are recruited into the groups. Hyman and Li [39] studied a model
that considered susceptibility of individuals. In their model, new individuals
were distributed into the subgroups of susceptible, based on their inherent
susceptibility. According to this, we ask the question: does the manner new
individuals are recruited into the risk groups matter?
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In any modeling approach, it is important to know how many individuals
are in a given risk group. However, this has been not possible for surveys
as individuals may not give correct information about their behaviour or
disease related information. With this, different assumptions are being made
regarding the initial population groups. Therefore, initialization is also an
important aspect in producing predictive estimates of the HIV impact in the
population since the more people are assumed not to be at risk, the smaller
the impact of the disease. In that case, we ask a question: how does the
initial size of the risk groups change model results?
Since it has not been easy to identify or obtain information about individu-
als’ risk levels, modellers are required to assume values and we ask another
question: How do assumptions about risk groups affect predictive estimates
of the spread of the disease?
In this chapter, we focus, investigating in a numerical approach the above
questions by extending the simple model for the spread of HIV developed in
chapter 2 to include risk groups.
4.2 Including the NOT group
4.2.1 With recruitment proportional to the size of the
group
This section investigates the effect of introducing the non risk group of in-
dividuals (NOT group). We assume a community that has two groups of
people with no interaction between them. One of them is exposed to HIV
4.2. Including the NOT group 68
infection and the other is not. New individuals are recruited into their re-
spective groups at a rate proportional to the size of the group. That is, those
born by the NOT group X(t) are also assumed to be NOT at risk and those
born by the risk group (Z(t)+Y (t) ) are assumed to be at risk. Thus, with all
parameter definitions and conditions remaining similar to the models studied
in the previous chapters, we can write our system of equations as follows:
dX(t)
dt
= bX(t)− µX(t)
dZ(t)
dt
= b(Z(t) + Y (t))− r
Z(t)Y (t)
N(t)
− µZ(t) (4.1)
dY (t)
dt
= r
Z(t)Y (t)
N(t)
− µY (t)− γY (t)
With N(t) = X(t) + Z(t) + Y (t) and dN(t)
dt
= (b− µ)N(t)− γY (t)
Writing the system of equations above in terms of proportions, we have:
dx(t)
dt
= γx(t)y(t)
dz(t)
dt
= by(t)− rz(t)y(t) + γz(t)y(t) (4.2)
dy(t)
dt
= rz(t)y(t)− by(t)− γy(t) + γy2(t)
where x(t) + z(t) + y(t) = 1
Model outcomes
Since the NOT fraction x(t) satisfies x(t) = 1−z(t)−y(t), we can work with
the last two equations in (4.2). At the equilibrium state, dz(t)
dt
= dy(t)
dt
= 0
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and therefore,
by∗ − rz∗y∗ + γz∗y∗ = 0 (4.3)
rz∗y∗ − by∗ − γy∗ + γy∗2 = 0 (4.4)
We see that, equation (4.3) is satisfied when y∗ = 0 or z∗ = b
r−γ
.
Substituting y∗ = 0 into equation (4.4) we see that both equations (4.3) and
(4.4) are satisfied for any value of z∗. If we substitute z∗ = b
r−γ
into equation
(4.4) we obtain y∗ = 1− b
r−γ
. Therefore, we have two equilibria of which one
is a disease free equilibrium DFE = (z∗, 0) with 0 < z∗ ≤ 1 and the other is
an endemic equilibrium given by EEP = (z∗, y∗) = ( b
r−γ
, 1− b
r−γ
).
But from equation (4.2), one can see that the solution x(t) can only be zero
if and only if x(0) = 0. Otherwise x(t) > 0 for all t. But from the equilibria
obtained, the endemic equilibrium point has shown that the equilibrium value
for x∗ is zero. For a population that has a non risk group, x(0) is never
zero. Therefore, we can discard the endemic equilibrium point as it is not
applicable according to the demand of the model. Thus, only the disease
free equilibrium holds. However, this disease free equilibrium depends on
the initial conditions as we see from the phase portrait diagram shown below
(figure 4.1).
The long-term behaviour of the solutions
From the phase portrait above (figure 4.1), limt→∞ z(t) > 0 if z(0) > 0 and
limt→∞ y(t) = 0 for all initial values (z(0), y(0)). This means that every
orbit in the plane tends to an equilibrium point on the line y = 0, that is,
eventually all infectives die, and the disease dies out.
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Figure 4.1: A phase portrait showing the dependence of the disease free equilib-
rium on initial conditions. Parameters: b = 0.03, µ = 0.02, γ = 0.1, and r = 0.5
Our model has shown a distinctive characteristic behaviour of a typical epi-
demic outbreak; that an infective fraction curve must first increase from an
initial value near zero, reach peak, and then decrease towards zero as a func-
tion of time (figure 4.1 and 4.2). The susceptible fraction z(t) is also shown
to decrease, but the final susceptible fraction is not zero (i.e. z(∞) > 0), in
fact it is easy to see that z∗ > b/(r − γ).
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Figure 4.2: A Time series diagram for the proportions. Parameters: b = 0.03,
µ = 0.02, γ = 0.1, and r = 0.5 at x(0) = 0.5, z(0) = 0.499 and y(0) = 0.001.
4.2.2 With recruitment proportional to the total pop-
ulation
In this model, one new parameter is introduced: p, the recruitment fraction.
The equation for the infective class (Y ) remains as in the basic model. This
follows the assumption we made in chapter 2 that vertical transmission is not
taken into account. Due to this assumption, our extended model describes
the dynamics of the disease with new individuals recruited only into the
NOT group (X) and the susceptible class (Z). The model assumes that even
though some of the new individuals might have been born by individuals
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who are exposed to infection, they may not inherit their parents behaviour.
And therefore they are recruited into the NOT group. Some of those born
by individuals who are completely not exposed to infection may also develop
risk behaviour and therefore they are recruited into the susceptible class.
That is, of the total number of offspring of the total population, bN(t), a
fraction p are recruited into X, while fraction 1−p are recruited into Z. Our
model is thus given by:
dX(t)
dt
= pbN(t)− µX(t)
dZ(t)
dt
= (1− p)bN(t)− r
Z(t)Y (t)
N(t)
− µZ(t) (4.5)
dY (t)
dt
= r
Z(t)Y (t)
N(t)
− µY (t)− γY (t)
With population size N(t) being X(t) + Z(t) + Y (t) which changes dynami-
cally as
dN(t)
dt
= (b− µ)N(t)− γY (t) (4.6)
All other parameters have similar definitions as in previous models.
Following a similar calculation, we can now write the above equations in
proportions as:
dx(t)
dt
= pb− bx(t) + γx(t)y(t)
dz(t)
dt
= (1− p)b− bz(t)− rz(t)y(t) + γz(t)y(t) (4.7)
dy(t)
dt
= rz(t)y(t)− by(t)− γy(t) + γy2(t)
where x(t) + z(t) + y(t) = 1 and
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dN(t)
dt
= (b− µ− γy(t))N(t) (4.8)
Model outcomes
We define a threshold quantity
R = rz(t)/(γ + b) (4.9)
as a replacement number of our model. This quantity depends on the sus-
ceptible proportion z(t) at any point in time. We also found two equilibrium
points,
• Equilibrium 1: No disease is found to establish itself. This is a trivial
outcome of the model and it is given by (x∗, z∗, y∗) = (p, 1− p, 0). At
this point, we can write the model replacement number in equation
(4.9) as RDFE = r(1 − p)/(b + γ). Using the normal method of local
stability, the eigenvalues obtained from the Jacobian matrix at this
equilibrium are as follows: λ1 = λ2 = −b and λ3 = (b+ γ) [RDFE − 1].
If RDFE < 1, we find that λ1,2,3 < 0 and therefore, the equilibrium is
stable. Otherwise, λ1,2 < 0 while λ3 > 0. For this case, this point is
unstable.
• Equilibrium 2: A disease establishes itself and persists. This point is
given by:
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x∗ =
√
Axr2 + (−4 b γ2 p− 2 γ3 + 2 b γ2) r + γ4 +Bx
2 γ r
z∗ =
√
4 b γ p r2 + γ2 r2 − 2 b γ r2 +Bz + Az
2 r2 − 2 γ r
y∗ =
−
√
4 b γ p r2 + γ2 r2 − 2 b γ r2 +By + Ay
2 γ r − 2 γ2
(4.10)
where
Ax = 4 b γ p+ γ
2 − 2 b γ + b2
Bx = (γ − b) r − γ
2
Az = (γ + b) r − γ
2
Bz = b
2 r2 − 4 b γ2 p r − 2 γ3 r + 2 b γ2 r + γ4
Ay = (γ + b) r − γ
2 − 2 b γ
By = b
2 r2 − 4 b γ2 p r − 2 γ3 r + 2 b γ2 r + γ4
To perform the stability analysis of this point is fairly complicated,
therefore, we use a numerical approach, to study how results change as
a function of our new parameter.
Long term effect of the recruitment fraction
On the equilibrium
Our endemic equilibrium above (equation 4.10) has a dependence on our
new parameter, the recruitment fraction, p. While keeping all other param-
eters unchanged, we study its effect on the equilibrium by the use of phase
diagrams (figure 4.3). The findings from this investigation show that the en-
demic equilibrium is stable (figure 4.3). But the equilibrium shifts when the
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recruitment fraction is varied. When this parameter is increased, more new
individuals are recruited into the NOT group which then makes a susceptible
group small. This leads to few infections and as infections continue, deaths
occurs and hence a low level in the stability points is attained.
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Figure 4.3: Phase portraits showing the shifting pattern of the endemic equilib-
rium due to change in the recruitment fraction p at different initial conditions. p
increases from top left to bottom right with p = 0.01, 0.2, 0.5 to 0.99 respectively.
Parameters: b = 0.03, µ = 0.02, γ = 0.1, r = 0.5
Although the equilibrium point is dependent on the new parameter, it is not
influenced by initial conditions. This implies that, in any community, the
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development of the disease in a long term does not depend on how many
individuals were initially subject to infection. Although, the initial division
is important in the early stage of the epidemic.
On the proportions
Dividing a population into risk and non-risk groups of uninfected individuals
means a careful recruitment of new individuals into the groups is required.
Results from our model have shown that, when the recruitment fraction is
increased, fewer new individuals are recruited into the susceptible group and
more of the them into the non-risk group (figure 4.4). As expected, this is
found to decrease the proportion of the infected group as the majority of in-
dividuals in the population are not subjected to infection. As infections take
place in the small risk group, this group decreases leading to low infections
in the long term.
Although the rise in the curves for the proportions of infected individuals
might be quite similar at low t for a small change in the recruitment fraction,
the long term results still show a difference (figure 4.4). This is due to the
fact that, when p is increased, the risk group is increased by a smaller value
and hence it gets saturated at lower levels at large t. This then reduces the
number of individuals getting infected or entering the infected group.
Another result found from our simulation is that, the recruitment fraction
does not affect the peaking property of an epidemic curve. Even if the epi-
demic does not show a significant impact, the peak in the prevalence does not
disappear. Instead its occurrence continues to exist at all values of p ∈ [0, 1].
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Figure 4.4: Time series diagrams at different values of the recruitment fraction
parameter p. p increases from top left to bottom right with p = 0.01, 0.2, 0.5 to
0.99 respectively. Parameters: b = 0.03, µ = 0.02, γ = 0.1, r = 0.5
4.3 Risk variations
In this section, we further extend the simple model studied in chapter 2. The
extension is made through the introduction of an equation describing levels
of risk to infection. This equation represents a susceptible population (Z1)
in which the risk level varies between high and low values. We assume that
the risk level for the second group (Z = Z2) does not change. The model
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does not include direct or individual parameters which are responsible for
the change of a risk behavior of individuals (e.g. concelling, education, STI
or STDs, etc). We assume a parameter φ to describe only the relative risk
level of the subgroup, Z1 (i.e. individuals are assumed to have homogeneous
risk). A reduction of φ represents a decrease in risk factors of individuals in
group Z1.
Since we have divided our susceptible group into two subgroups, then the next
task is to decide how we are to recruit new individuals into these groups. We
assume a similar manner of new individuals entrance into these two groups
as in the model discussed in section 4.2.2. A fraction p of new individuals
bN(t) are recruited into the first risk group ( Z1) and 1− p into the second
risk group (Z2). All other parameter definitions remain similar to those used
in the previous models. The model equations describing the dynamics of our
population are given as follows:
dZ1(t)
dt
= pbN(t)−
rφZ1(t)Y (t)
N(t)
− µZ1(t)
dZ2(t)
dt
= (1− p)bN(t)−
rZ2(t)Y (t)
N(t)
− µZ2(t) (4.11)
dY (t)
dt
=
rφZ1(t)Y (t)
N(t)
+
rZ2(t)Y (t)
N(t)
− µY (t)− γY (t)
With N(t) = Z1t) + Z2(t) + Y (t) and
dN(t)
dt
= (b − µ)N(t) − γY (t) and the
corresponding proprotions are
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dz1(t)
dt
= pb− rφz1(t)y(t)− bz1(t) + γz1(t)y(t)
dz2(t)
dt
= (1− p)b− rz2(t)y(t)− bz2(t) + γz2(t)y(t) (4.12)
dy(t)
dt
= rφz1(t)y(t) + rz2(t)y(t)− by(t)− γy(t) + γy
2(t)
where z1(t) + z2(t) + y(t) = 1
4.3.1 The role of risk to infection in determining model
outcomes
To illustrate the effect of changing the risk levels, we run simulations using
the system with proportions (equation 4.12). Since our main concern is to
study the behaviour that may be due to the risk levels, we compare different
scenarios of changing φ with equal division in recruitment of new individuals
into the two risk groups.
If the risk parameter (φ) is decreased to lower values, a low rise in the preva-
lence curve occurs (figure 4.5). It has also been found that the prevalence
curve of the disease peaks and remains endemic at a relatively low level when
group (Z1) is at low risk. We also note that in the absence of any risk factor
(when φ = 0), the model in (equation 4.11) becomes the same to the model
in equation (4.5).
When φ is increased to higher values, the prevalence curve (figure 4.5(b)),
does not peak. The curve shows that the disease remains endemic at a very
high level. For φ = 1, Z1 becomes like to Z2 and therefore forming a single
group with a uniform risk level as in the original form (see equation (2.1)).
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Figure 4.5: Effect of the risk parameter φ (a)Top: φ = 0.1 and (b)Bottom: φ = 0.5
Parameters: p = 0.5, b = 0.03, µ = 0.02, γ = 0.1, r = 0.5
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4.4 Summary and conclusion
In this chapter we have investigated some of the key properties of epidemic
models. The aspect of dividing new individuals into the risk groups was
shown to have a critical impact on results. Our study on this aspect has
shown that new individuals born by individuals who have no risk behaviour,
should retain or inherit their parents behaviour. This would enable the dis-
ease to die out in the long term.
Furthermore, our investigation explored some initialization aspects of the
uninfected groups. Our results show, that in the case of recruitment staying
within its group, a small change in the initial conditions may result in a
large change in the equilibrium point. However, from some initial division
onwards, the equilibrium may continue to be fairly stable.
The effect of different risk levels was also investigated. It was found that a
group risk level is the determinant of the occurrence of a peak in the epidemic
curve. As most epidemic curves have been showing peaks, with our results
we can conclude that these peaks are due to the presence of groups which
have low risk of disease infection. Therefore, it should not be generalized
that a peak in prevalence occurs in any population.
Chapter 5
Discussion and Conclusion
5.1 Summary and conclusions
This study has been concerned with developing a very simple HIV/AIDS
spread model which is then extended to explain different properties that
arise in any population where HIV exists. We were specifically interested
in understanding how these properties influence the spread of HIV/AIDS
and their effects on predictions. Specifically, we wanted to determine the
contribution of these properties in making HIV/AIDS predictive estimates
close to reality, as HIV surveillance systems and methods are improving,
and the dynamic behaviour of the disease is becoming clearly understood.
In studying these properties, we raised some other issues such as the rate
of HIV transmission, the survival period of HIV infected individuals, the
degree of risk behaviour in acquiring HIV, the manner new individuals are
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recruited into different risk groups and the decision on how many individuals
are initially present in a given risk group.
To explore these properties and describe the contribution of stages of HIV
progression in the spread of HIV and in changing predictive estimates, we
used the simple HIV model as a starting point. After studying the model for
our quantitative study, and incorporating the stages explicitly, we showed
that this inclusion of the stages qualitatively captured the dynamics we be-
lieve to be important in the early stages of HIV progression. A search in
the literature resulted in reasonable estimates for many of the parameters
in the models, and analysis of the model equations provided conditions that
were used to estimate the remaining parameters, the transmission rates. We
discovered that, there are differences in results between the two models, with
predictions being higher in a short term when stages are considered and low
when they are not. It appears that the main driver is the presence of the
primary stage. These findings are confirmed by the results obtained from
clinical studies [4, 5].
In an attempt to understand what key details were left out of the staged
model, we extended our model to include other reasonable details. In the
extended model, we assumed that AIDS deaths have a profound effect on
both the spread of the disease and predictions. We altered the mechanism of
AIDS deaths occurrence and consider an explicit constant time delay for all
infected individuals from their initial infection to death. The main difference
occurs in the mortality rates curves as they depend much on how long infected
individuals live.
For further understanding of the key properties, our simple single staged
model in chapter (2) was then extended to include risk groups. It is shown
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that for the disease not to have a large impact on the population, the majority
of individuals must refrain from risk behaviour. This can lead to disease
clearance especially when new individuals do not develop risk behaviors (e.g.
NOT group), instead they inherit their parent’s behaviour.
In all models considered in this study, stages have shown an important role.
Their inclusion increases the prevalence level of the disease in the population
especially during its early development. The difference between the model
that considers a single group of infected individuals and the model with stages
(that divides infected individuals according to stages), is that with a single
group of infected people, all individuals in this group transmit the viruses
at an equal rate. In the staged model, individuals transfer the viruses to
uninfected individuals at different rates. It is this factor that is important.
The study has shown that even if the model with a single group of infected
individuals include all other factors, it still can not reproduce results of the
model with stages.
In addition, our study discovered an important feature in epidemiological
modelling and the spread of diseases. HIV/AIDS like other diseases, its
epidemic curves are claimed to rise to a peak and then decrease to a constant
value if the disease is assumed to persist in the population. This feature has
been occurring in survey data as well as in results predicted by mathematical
models of disease dynamics in populations. Our study revealed that, if the
population does not have risk groups, then this feature in epidemic curves
can not occur. As shown by our model results in chapter (2) and chapter
(3), in a long-term, the epidemic curves are not affected either by introducing
stages or time delay in AIDS mortality. The prevalence curves can only grow
to form a plateau but not a peak. This is true for prevalence curves, while
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curves for incidence or proportion of new infections can indeed have a peak.
The introduction of risk groups has lead to an occurrence of peaks in the
prevalence curves.
5.2 Limitations and future directions
In this study, we developed, expanded and improved on the simple HIV
spread model to address some specific questions on spread and predictions
of HIV/AIDS. Our results have been based on estimated parameter values
which may however not apply in some cases. All of the models in this study
dealt with an idealized situation. By creating a model using differential
equations, we have assumed that all individuals in a given stage or risk
group in acquiring the disease, modeled with same parameter values. A
more realistic model would allow for the possibility that parameter values
are not constant over time, and are different in different regions.
The assumption that the total population is not constant has lead to in-
creased non linearity of the terms in the proportion forms of the models. We
have assumed that the total population decreases asymptotically due to the
disease persistence. This has lead us to approximate the endemic equilib-
rium points in some models. However, this assumption is not applicable to
the models which incorporated risk groups. The total population might not
decrease asymptotically due to the presence of groups which are at less risk
or no risk at all to infection.
Our study is also limited by having few parameters in the models. For
example, we have studied the effect of changing survival periods of infected
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individuals in a general case. It could be interesting if one would include
parameters that describe the effects due to treatment programmes directly.
The time delay introduced in the model studied in chapter (3) assumed that
people die following a step function distribution which is an extreme case. It
would be interesting to have a distribution which is between the step function
and an exponential distribution to explain the occurrence of AIDS deaths.
Another limitation of this work is that the models studied considered a single
sex group of people. It does not divide individuals according to gender.
Both males and females are treated equally and the HIV transmission rate
is equally considered. In reality, females are at more risk than males [23, 21,
22, 40, 36]. Although the models in chapter (4) divides the population into
subgroups like the NOT group and other groups with different risk levels,
still the models do not allow movement of individuals from one risk group to
another. It would be helpful to allow these movements as some individuals
refrain from risk behaviour while others are increasing risk.
In general, our work has provided an understanding of how difficult it can
be to produce quality HIV/AIDS information using mathematical models.
However, a model that combines all the features studied in this thesis would
be an added advantage. As HIV/AIDS data has been improving through
improvements in collection methods, clear understanding of the disease and
its characteristics etc, more complexity in models will be needed.
Appendix A
Determination of the
reproduction number for the
staged model
We rearrange the system (2.22) by starting with the infectious groups and
ending with the susceptible group as
(
dy1(t)
dt
,
dy2(t)
dt
,
dz(t)
dt
)T . (A.1)
From our new system (A.1), we define a matrix F with new infections and
a matrix V by negating the inflow and outflow of individuals in the system.
Thus
88
F =


r1zy1 + r2zy2
0
0

 (A.2)
V =


(ρ+ b)y1 − γy1y2
−ρy1 + (γ + b)y2 − γy
2
2
b(1− z) + r1zy1 + r2zy2 − γzy2

 (A.3)
Differentiating F and V with respect to the infected subgroups y1 and y2 at
the disease free equilibrium, the following matrices are obtained:
F =

 r1 r2
0 0

 (A.4)
V =

 (ρ+ b) 0
−ρ (γ + b)

 (A.5)
Next we find the a Jaconbian matrix using F and the inverse of a matrix V
FV −1 =


r1
ρ+b
+ r2ρ
(ρ+b)(γ+b)
r2
γ+b
0 0

 (A.6)
The eigenvalues of equation (A.6) are λ1 =
r1
ρ+b
+ r2ρ
(ρ+b)(γ+b)
and λ2 = 0.
Appendix B
Computer programs
The python programs presented here are used for the simulation of the sys-
tems with proportions.
B.1 Simple HIV model program
#Importing the modules
from scipy import *
from scipy.integrate import odeint
#Parameter assignment
b = 0.03
rho = 0.12
mu = 0.02
r = 0.4 #This parameter can vary
# Function definitions for f0 = dz/dt, y[0] = z, y[1]=y, y[2] = dN/dt
def f0(y,t):
return b - r*y[1]*y[0] - b*y[0] + rho*y[0]*y[1]
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def f1(y,t):
return r*y[1]*y[0] -b*y[1] - rho*y[1] + rho*y[1]*y[1]
def fN(y,t):
return (b - mu - rho*y[1])*y[2]
y_dot = [0,0,0]
def f(y,t):
y_dot[0] = f0(y,t)
y_dot[1] = f1(y,t)
y_dot[2] = fN(y,t)
return y_dot
#Initialization of z0 and y0
y_initial = [0.999,0.001,1.0] # Can be changed
t = arange(0.,500.,0.01) # Times at which y is calculated
y = odeint(f,y_initial,t) # calling odeint solver
fout = open(’simple_model.data’,’w’)
data=[]
for i in range(len(t)):
data.append([t[i], y[i][0], y[i][1], y[i][2]])
print >> fout, array(data) #writing data to a file for plotting
fout.close()
#computing data for y* and ra=r
data1 = []
for y_star in arange(0.,0.9,0.01):
ra =((b + gamma) - gamma*y_star)/(1-y_star)
data1 = data1 + [[y_star,ra]]
equilibData = take(data1,[0,1],axis = 1)
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B.2 Simple staged model program
from scipy import *
from scipy.linalg import *
import math
#parameter assignment: b,mu and rho are assumed constant
b = 0.03
mu = 0.02
r1 = 4.0
r2 = r1/12
rho = 6.0
gamma = 0.1
fout = open(’staged_model.data’,’w’)
#Function definition for the model equations
def fy1(t,y1,y2): #for dy1/dt
equationy1=r1*(1-y1-y2)*y1+r2*(1-y1-y2)*y2-(rho + b)*y1+gamma*y1*y2
return equationy1
def fy2(t,y1,y2): #for dy2/dt
equationy2 = rho*y1 - (gamma + b)*y2 + gamma*y2*y2
return equationy2
def fN(t,y2,N): #for dN/dt
equationN = (b - mu - gamma*y2)*N
return equationN
#Defining the rungekutta order four function
def rk4(fy1,fy2,fN,t,y1,y2,N,h,tmax):
table = [[t,y1,y2,N]]
while t < tmax:
d1 = h*fy1(t,y1,y2)
p1 = h*fy2(t,y1,y2)
g1 = h*fN(t,y2,N)
d2 = h*fy1(t+0.5*h,y1+0.5*d1,y2+0.5*p1)
p2 = h*fy2(t+0.5*h,y1+0.5*d1,y2+0.5*p1)
g2 = h*fN(t+0.5*h,y2+0.5*p1,N+0.5*g1)
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d3 = h*fy1(t+0.5*h,y1+0.5*d2,y2+0.5*p2)
p3 = h*fy2(t+0.5*h,y1+0.5*d2,y2+0.5*p2)
g3 = h*fN(t+0.5*h,y2+0.5*p2,N+0.5*g2)
d4 = h*fy1(t+h,y1+d3,y2+p3)
p4 = h*fy2(t+h,y1+d3,y2+p3)
g4 = h*fN(t+h,y2+p3,N+g3)
t += h
y1 += (d1+2.*d2+2.*d3+d4)/6.
y2 += (p1+2.*p2+2.*p3+p4)/6.
N += (g1+2.*g2+2.*g3+g4)/6.
mortalityRate = gamma*y2
table.append([t,y1,y2,N])
print >> fout,’ %f %f %f %f %f’ %(t,y1,y2,N,mortalityRate)
return table
#Function call
mytable = rk4(fy1,fy2,fN,0,0.001,0.0,1.0,0.1,500)
# Computation of the reproduction nummber,Xi
Ry1 = r1/(rho+b)
Ry2 = r1/((gamma+b)*12)
Xi = Ry1 + rho*Ry2/(rho+b)
print >> fout,’# Ry1=%f Ry2=%f Xi=%f r1=%f r2=%f’ %(Ry1,Ry2,Xi,r1,r2)
fout.close()
#computing r1a=r1 for y2_st=y2* in range(0,1)
data1 = []
for y2_st in arange(0.,0.95,0.01):
c_a = b - mu - gamma*y2_st #c_a = c
y1_st = ( (mu+gamma+c_a)/rho )*y2_st
kappa = (mu + gamma + c_a)/rho
numerator = (b + rho - gamma*y2_st)*kappa
denominator = ((1-(kappa+1)*y2_st)*kappa)+((1 - (kappa+1)*y2_st)/12)
r1a = numerator/denominator
r2a = r1a/12
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data1 = data1 + [[y2_st,y1_st,r1a]]
equlibriumData = take(data1,[0,1,2],axis = 1)
B.3 Delay model program
from scipy import *
from scipy.linalg import *
from math import *
b = 0.03
mu = 0.02
r1 = 4.0
r2 = r1/12
rho = 6.0
delay = 10 #delay = tau
fout = open(’delaymodel.data’,’w’)
# Function definitions
def fz(t,z,y1,y2,y1delay,Ndelay,N):
equationz=b-b*z-r1*z*y1 -
r2*z*y2+rho*exp(-delay*mu)*y1delay*z*(Ndelay/N)
return equationz
def fy1(t,z,y1,y2,y1delay,Ndelay,N):
equationy1 = r1*z*y1 + r2*z*y2 - (b + rho)*y1 +
rho*exp(-delay*mu)*y1*y1delay*(Ndelay/N)
return equationy1
def fy2(t,y1,y2,y1delay,Ndelay,N):
equationy2=rho*y1-b*y2-rho*exp(-delay*mu)*y1delay*(1-y2)*(Ndelay/N)
return equationy2
def fN(t,y1delay,Ndelay,N):
equationN = (b - mu)*N - rho*exp(-delay*mu)*y1delay*Ndelay
return equationN
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#defining a runge kutta function
def RK4(fz,fy1,fy2,fN,t,z,y1,y2,N,h,tmax):
table = [[t,z,y1,y2,N]]
i = 0
while t < tmax:
if t-h <=delay :
y1delay = 0
Ndelay = 0
i+=1
else:
y1delay = table[i-101][2]
Ndelay = table[i-101][4]
i+=1
k1 = h*fz(t,z,y1,y2,y1delay,Ndelay,N)
d1 = h*fy1(t,z,y1,y2,y1delay,Ndelay,N)
p1 = h*fy2(t,y1,y2,y1delay,Ndelay,N)
g1 = h*fN(t,y1delay,Ndelay,N)
k2=h*fz(t+0.5*h,z+0.5*k1,y1+0.5*d1,y2+0.5*p1,y1delay+0.5*d1,
Ndelay+0.5*g1,N+0.5*g1)
d2=h*fy1(t+0.5*h,z+0.5*k1,y1+0.5*d1,y2+0.5*p1,y1delay+0.5*d1,
Ndelay+0.5*g1,N+0.5*g1)
p2 = h*fy2(t+0.5*h,y1+0.5*d1,y2+0.5*p1,y1delay+0.5*d1,
Ndelay+0.5*g1,N+0.5*g1)
g2 = h*fN(t+0.5*h,y1delay+0.5*d1,Ndelay+0.5*g1,N+0.5*g1)
k3=h*fz(t+0.5*h,z+0.5*k2,y1+0.5*d2,y2+0.5*p2,y1delay+0.5*d2,
Ndelay+0.5*g2,N+0.5*g2)
d3=h*fy1(t+0.5*h,z+0.5*k2,y1+0.5*d2,y2+0.5*p2,y1delay+0.5*d2,
Ndelay+0.5*g2,N+0.5*g2)
p3 = h*fy2(t+0.5*h,y1+0.5*d2,y2+0.5*p2,y1delay+0.5*d2,
Ndelay+0.5*g2,N+0.5*g2)
g3 = h*fN(t+0.5*h,y1delay+0.5*d2,Ndelay+0.5*g2,N+0.5*g2)
k4 = h*fz(t+h,z+k3,y1+d3,y2+p3,y1delay+d3,Ndelay+g3,N+g3)
d4 = h*fy1(t+h,z+k3,y1+d3,y2+p3,y1delay+d3,Ndelay+g3,N+g3)
p4 = h*fy2(t+h,y1+d3,y2+p3,y1delay+d3,Ndelay+g3,N+g3)
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g4 = h*fN(t+h,y1delay+d3,Ndelay+g3,N+g3)
t += h
z += (k1+2.*k2+2.*k3+k4)/6.
y1 += (d1+2.*d2+2.*d3+d4)/6.
y2 += (p1+2.*p2+2.*p3+p4)/6.
N += (g1+2.*g2+2.*g3+g4)/6.
mortalityRate=rho*exp(-delay*mu)*y1delay*Ndelay/N
table.append([t,z,y1,y2,N,M])
print >> fout,’%f %f %f %f %f %f %f %f %f
%f’%(t,z,y1,y2,N,mortalityRate,M,y1delay,Ndelay)
return table
print >> fout,’ #r1 = %f r2 = %f mu = %f b = %f rho = %f delay = %f’
%(r1,r2,mu,b,rho,delay)
results = RK4(fz,fy1,fy2,fN,fdeath,0,0.999,0.001,0,1,0,0.1,400)
fout.close()
# Calculating data for r1,y1* and y2* in a given range of
#alpha* for delay = 10years
datar1=[]
for alpha in arange(1.22,8.,0.01):
y1a = (log(alpha) + delay*(b - mu))/(delay*rho*exp(-delay*mu)*alpha)
y2a = (rho*y1a*(exp(-delay*mu)*alpha - 1))/
(rho* exp(-delay*mu)*alpha*y1a - b )
za = 1-y1a-y2a
numerator = (rho + b)*y1a - rho*exp(-delay*mu)*alpha*y1a*y1a
denomenator = (1-y1a-y2a)*(y1a + (y2a/12))
r1a = (numerator/denomenator)
r2a=r1a/12
datar1 = datar1 + [[alpha,r1a,y1a,y2a,za]]
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B.4 Model with NOT group program: part
one
from scipy import *
from scipy.integrate import odeint
b = 0.03
gamma = 0.1
r1 = 6.0 # for comparison, r2 = r=r1/12
r = r1/12
mu = 0.02
# Functions definitions with y[0] = x, y[1]=z, y[2]=y, y[3] = N
#f0 = dx/dt
def f0(y,t):
return gamma*y[0]*y[2]
#f1 = dz/dt
def f1(y,t):
return b*y[2] - r*y[1]*y[2] + gamma*y[1]*y[2]
#f1 = dy/dt
def f2(y,t):
return r*y[1]*y[2] - (b + gamma)*y[2] + gamma*y[2]*y[2]
#fN = dN/dt
def f3(y,t):
return (b - mu - gamma*y[2])*y[3]
y_dot = [0,0,0,0]
def f(y,t):
y_dot[0] = f0(y,t)
y_dot[1] = f1(y,t)
y_dot[2] = f2(y,t)
y_dot[3] = f3(y,t)
return y_dot
#Initialization of x0, z0, y0 and N0, can be changed
y_initial = [0.5,0.499,0.001, 1.0] #N0 can be any
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t = arange(0.,500.,1.)
y = odeint(f,y_initial,t)
fout = open(’modelNorecruit.data’,’w’)
data=[]
for i in range(len(t)):
data.append([t[i], y[i][0], y[i][1], y[i][2], y[i][3] ])
all = take(data, [0, 1, 2, 3, 4], axis = 1)
print >> fout, " b = %f r = %f mu = %f gamma = %f" %(b,r,mu,gamma)
print >> fout, All
fout.close()
B.5 Model with NOT group program: part
two
from scipy import *
from scipy.integrate import odeint
b = 0.03
p = 0.01
gamma = 0.1
r1 = 6.0
r = r1/12
mu = 0.02
# Functions definitions with y[0] = x, y[1]=z, y[2]=y, y[3] = N
#f0 = dz/dt
def f0(y,t):
return p*b - b*y[0] + gamma*y[0]*y[2]
#f1 = dz/dt
def f1(y,t):
return (1-p)*b -b*y[1] - r*y[1]*y[2] + gamma*y[1]*y[2]
B.6. Risk variation model program 98
#f2 = dy/dt
def f2(y,t):
return r*y[1]*y[2] - (b + gamma)*y[2] + gamma*y[2]*y[2]
#fN = dN/dt
def f3(y,t):
return (b - mu - gamma*y[2])*y[3]
y_dot = [0,0,0,0]
def f(y,t):
y_dot[0] = f0(y,t)
y_dot[1] = f1(y,t)
y_dot[2] = f2(y,t)
y_dot[3] = f3(y,t)
return y_dot
#Initialization of x0, z0, y0 and N0
#y_initial = [0.5,0.499,0.001, 1.0]
t = arange(0.,500.,1.)
y = odeint(f,y_initial,t)
fout = open(’modelRecruit.data’,’w’)
data=[]
for i in range(len(t)):
data.append([t[i], y[i][0], y[i][1], y[i][2], y[i][3] ])
Alldata = take(data, [0, 1, 2, 3, 4], axis = 1)
print >> fout, " b = %f p = %f r = %f mu = %f gamma = %f" %(b,p,r,mu,gamma)
print >> fout, Alldata
fout.close()
B.6 Risk variation model program
#Importing modules
from scipy import *
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from scipy.integrate import odeint
#Parameter asignment
b = 0.03
p = 0.5 #Can be changed
gamma = 0.1
r1 = 6.0
r = r1/12
mu = 0.02
phi = 0.5 #Can be changed
# Functions definitions for f0 = dz1/dt, y[0] = z1, y[1]=z2,
# y[2]=y, y[3] = N
def f0(y,t):
return p*b - r*phi*y[0]*y[2] - b*y[0] + gamma*y[0]*y[2]
def f1(y,t):
return (1-p)*b - r*(1-phi)*y[1]*y[2] - b*y[1] + gamma*y[1]*y[2]
def f2(y,t):
return r*phi*y[0]*y[2] + r*(1-phi)*y[1]*y[2] -
(b + gamma)*y[2] + gamma*y[2]*y[2]
def f3(y,t):
return (b - mu - gamma*y[2])*y[3]
y_dot = [0,0,0,0]
def f(y,t):
y_dot[0] = f0(y,t)
y_dot[1] = f1(y,t)
y_dot[2] = f2(y,t)
y_dot[3] = f3(y,t)
return y_dot
#Initialization of x0, z0, y0 and N0
y_initial = [0.2,0.799,0.001, 1.0]
t = arange(0.,500.,1.)
y = odeint(f,y_initial,t)
fout = open(’riskVariation_model.data’,’w’)
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#data collection
data=[]
for i in range(len(t)):
data.append([t[i], y[i][0], y[i][1], y[i][2], y[i][3] ])
All = take(data, [0, 1, 2, 3, 4], axis = 1)
print >> fout, "# b = %f p = %f gamma = %f r = %f phi = %f mu = %f"
%(b,p,gamma,r,phi,mu)
print >> fout, All
fout.close()
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